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Zusammenfassung 
Die Marvel-Technologie wurde getestet, um die Frakturheilung unter Verwendung eines 
elektromagnetischen Feldes (PEMF- Pulsed Electromagnetic Field) zu verbessern und 
zu beschleunigen. 
Eine standardisierte 3 mm-Tibia-Osteotomie wurde bei 14 Schafen (8 TI, 6 CI) 
durchgeführt, um eine Fraktur zu imitieren, die ein Modell mit einer nicht kritischer 
Frakturgröße darstellt. Eine Osteotomie von 17 mm wurde gemacht, um die 
Heilungsreaktion bei einem Defekt mit kritischer Größe zu testen. 12 von 15 Schafen 
bekamen ein autologes Knochentransplantatmaterial (6 TI, 6 CI). Alle TI-Schafe wurden 
über 9 (3mm Defekt) bzw. 12 (17mm Defekt) Wochen täglich mit PEMF behandelt. Die 
Heilungsreaktion wurde mit Röntgenaufnahmen, Mikro-CT, Biomechanik und 
Histologie bewertet. 
Das 3-mm-Spaltmodell zeigte sowohl bei TI als auch bei CI eine gute Heilung. Ein Trend 
für höhere Werte in der Biomechanik (zweifache Zunahme, p = 0,081) und Kallusdichte 
(p = 0,053) wurde in TI beobachtet. Dies wurde durch den histologisch beobachteten 
dichten, gut integrierten und regelmäßig orientierten neuen Knochen bestätigt. 
Im 17-mm-Defektmodell erreichten die TI-Tibiae 67% der Torsionssteifigkeit der 
gesunden Tibia, verglichen mit nur 30% der CI-Tibiae (p = 0,034). Das TI-
Kallusvolumen (p = 0,002) und die Dichte (p = 0,055) waren auch dem CI überlegen. 
Darüber hinaus zeigte TI eine schnellere und besser ausgeprägte radiographische, makro- 
und mikroskopische Heilung. 
Insgesamt beschleunigte und verbesserte die Marvel-Technologie den 
Knochenheilungsprozess und führte zu einer besseren neuen Knochenstruktur mit 





The Marvel technology was tested to enhance and accelerate fracture healing using 
Pulsed Electromagnetic Field (PEMF- Pulsed Electromagnetic Field).  
A 3mm standardized tibia osteotomy was created in 14 sheep (8 Test Item (TI), 6 Control 
Item (CI)) to imitate a fracture, representing a non-critical size model. Further, a 17mm 
gap was done to test the healing response in an augmented critical size defect. 12 sheep 
were augmented with autologous bone graft material (6 TI, 6 CI) and 3 sheep were not 
augmented. All TI sheep received daily treatments (PEMF) over 9 (3mm gap) resp. 12 
(17mm gap) weeks. The healing response was evaluated with radiographs, micro-CT, 
biomechanics and histology.  
The 3mm gap model showed good healing in both TI and CI. A trend for higher 
biomechanical values (2-fold increase, p=0.081) and callus density (p=0.053) was seen 
in TI. This was corroborated by the histologically observed dense, well integrated and 
regularly oriented new bone.  
In the 17mm graft model, the TI tibiae reached 67% of healthy tibia torsional stiffness 
compared to only 30% for CI tibiae (p=0.034). TI callus volume (p=0.002) and density 
(p=0.055) was also superior to CI. Moreover, TI exhibited a faster and more pronounced 
radiographic, macro- and microscopic healing.  
Overall, the Marvel technology accelerated and enhanced the bone healing process, with 
no related abnormalities or complications. This resulted in better new bone structure, 
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 Introduction 
 Clinical problem 
Bone fractures are one of the most commonly occurring injuries in both veterinary and 
human medicine. Despite all the improvements and advancements in fracture 
management, bone healing still remains clinically challenging. Complication rates in 
long bone and flat bone fractures are high with approximately 5 to 10 % of those fractures 
showing signs of impaired healing such as delayed union or in a worse case, becoming a 
non- union (Einhorn, 1995; Morshed, 2014). For the purpose of this thesis, focus will be 
set on long bone fractures. 
 Bone structure  
Bone is an organ with a very complex composition. The most outer part, the periosteum, 
is a thin membrane that covers almost the whole bone, apart from the bone areas within 
the joint capsule or those that function as tendon or ligament attachment. This membrane 
consists of two layers: fibrous and osteogenic. The fibrous layer is the outer one and 
contains numerous blood vessels, nourishing the bone. The osteogenic layer is where the 
osteoblasts are located and is thus responsible for bone growth and regeneration. 
The walls of a long bone are composed of cortical (compact) bone, which is the outer 
layer, and cancellous (spongy) bone- the inner part. The inner part of the diaphysis 
contains a medullary cavity containing the endosteal membrane and bone marrow.  
There are four main types of cells within bone tissue: osteogenic progenitor cells, 
osteoblasts, osteocytes and osteoclasts. The osteogenic progenitor cells are 
undifferentiated and can mature into osteoblasts. Osteoblasts are the bone forming cells, 
which get embedded in the bone matrix and become osteocytes. Osteocytes are the 
primary mature bone cells, the role of which is to maintain mineral density of the matrix. 
They are the type of cells that is most likely to be found in healthy bone. Osteoclasts are 
responsible for bone resorption. Bone homeostasis relies on a delicate balance between 




 Fracture healing 
Bone strength is naturally dependent on numerous factors, age and general health being 
amongst the most crucial ones. When a force applied against a bone is stronger than a 
bone itself, a fracture develops.  
During the whole healing process, achieving a certain degree of fragment stabilization 
and micromotion in order to provide mechanically favourable healing conditions is of 
the utmost importance. To achieve this degree of stabilization, the following surgical 
methods have been established: internal fixation using implants like plates, screws, nails, 
rods, wires, pins or external fixation. The latter involves using unilateral and circular 
fixators, or the combination of both, namely hybrid fixators. Additional stabilization can 
be provided by applying a cast or a splint. 
The functional healing of skeletal fractures is achieved upon the recovery of weight 
bearing (Saliev et al., 2019).  
  
During normal fracture healing, a cascade of multiple processes is initiated. Bones heal 
in two ways: through direct or indirect healing.  
Direct healing happens when bone fragments are tightly fixed together, therefore an 
anatomic reduction and perfectly stable conditions are a strict requirement. Healing 
occurs by direct involvement of osteoblasts and osteoclasts (Ghiasi et al., 2017; Marsell 
and Einhorn, 2011). 
Indirect healing is certainly more common when it comes to long bone fractures. Its main 
difference compared to direct healing comes from unstable healing conditions. Such 
situations happen in inoperable fractures or in cases where some degree of motion exists. 
This occurs, for instance, with intramedullary nailing, external fixation, internal fixation 
of complicated comminuted fractures (Marsell and Einhorn, 2011). This type of healing 
is enhanced by micromotion and weight- bearing and includes four phases: inflammation, 
soft callus formation, hard callus formation, remodelling. 
 Phase I: Inflammation  
The anabolic phase starts immediately after the bone structure has been disrupted. It is 
characterized by an increased local tissue volume and typically lasts up to seven days. 
The inflammation begins as the pro- inflammatory cytokines are released: TNF- Alpha, 
TGF- Beta, BMPs and Interleukins (IL-1beta, IL- 6, -17F, - 23), reaching a peak 24 hours 
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after the trauma has occurred. These molecules are responsible for accelerating the 
inflammatory reaction and recruitment of the cells required for tissue regeneration, such 
as monocytes, macrophages, neutrophils, basophils, dendritic cells, mast cells, T-cells 
and B-cells (Turner et al., 2014). 
At the same time, the hematoma, consisting of cells from both intramedullary and 
peripheral blood, is immediately formed and fills the fracture gap. Forming of the 
hematoma is a crucial part of the healing as it first acts as a temporary scaffold for the 
mesenchymal stem cells (MSCs) derived from the surrounding tissue and bone marrow. 
During the next days, granulation tissue formed by fibrin, collagen and reticulin slowly 
replaces the hematoma and bridges the fracture ends. Five to seven days after fracture, 
anabolic processes are accompanied by the catabolic ones. 
 Phase II: Soft callus formation  
Around one week after the trauma, the formation of soft, cartilaginous callus is initiated 
(Einhorn and Gerstenfeld, 2015), reaching its peak at day seven to nine. The progenitor 
cells in the endosteum and periosteum play a vital role in this process as they differentiate 
into osteoblasts and initiate the callus formation from the periphery towards the fracture 
line. The mesenchymal progenitor cells located near the fracture gap differentiate into 
fibroblasts, producing fibrous tissue, or differentiate into chondrocytes, creating 
cartilage, which replaces the granulation tissue formed in the previous phase (Wang et 
al., 2017).  
 Phase III: Hard callus formation 
The mechanisms leading to this transformation of the soft callus into the hard callus is 
called endochondral ossification. As the MSCs and progenitor cells differentiate into 
chondrocytes, the cartilage tissue is built. At that point, cartilage extracellular matrix 
mineralizes along with chondrocyte apoptosis. As a consequence, osteoblasts infiltrate 
the mineralized cartilage matrix and produce bone. This happens about 3 weeks after a 
fracture and typically lasts for three to four months until the soft callus is fully 




 Phase IV: Remodeling 
The last phase starts when the cartilage is fully resorbed and replaced by hard callus. It 
is then gradually transformed into a lamellar bone structure, just like what was there 
before the trauma. Reestablishment of a central medullary cavity also takes place. This 
dynamic process is regulated by hematopoietic- derived osteoclasts and mesenchymal- 
derived osteoblasts (Einhorn and Gerstenfeld, 2015; Ghiasi et al., 2017; Marsell and 
Einhorn, 2011; Pivonka and Dunstan, 2012; Pivonka and Komarova, 2010). 
It may take months or even years until this phase is fully completed.  In healthy adults, a 
balance between the osteoclastic resorption and osteoblastic activity is always 
maintained. It is mediated by a variety of molecules like growth factors, hormones, 
cytokines or matrix proteins (Ledda et al., 2015). 
 Neovascularization 
Concurrent to all of these processes, about 2-3 weeks after the fracture, 
neovascularization is established. The formation of new blood vessels, called 
angiogenesis, plays a vital role in the whole bone healing process. Better angiogenesis 
means a superior supply not only in cells that directly influence the healing (like MSCs, 
macrophages, neutrophils, monocytes, lymphocytes) but also in oxygen, nutrients and 
growth factors. It is therefore clear that impaired angiogenesis leads to insufficient supply 
of these components and may result in healing complications (Streit et al., 2016).  
 Impaired healing   
There are conditions, when a desirable healing effect is not achieved as the 
fibrocartilage fails to bridge the gap and calcify, resulting in either a non-union or a 
delayed bony union. The pathogenesis of this process often involves factors like fracture 
displacement, substantial fracture gap size, inadequate immobilization, damage of the 
surrounding soft tissue or fracture site infection (Gossling et al., 1992). The age of the 
patient is crucial (older patients have an increased complication risk) as well as 
concomitant diseases and disorders (diabetes, liver diseases, osteoporosis, bone tumors), 
mineral or vitamin deficiencies (especially calcium, vitamin D, vitamin C) or certain 
medications (anticoagulants, steroids). Smoking and radiotherapy have a documented 
detrimental effect on bone regeneration as well. In addition, the speed and success of 
initial management are often decisive factors in how the healing proceeds.  
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When a fracture healing is prolonged, meaning it does not heal within the anticipated 
time frame but some clinical or radiological evidence of proceeding healing is apparent, 
a delayed union is diagnosed (Griffin et al., 2011; Griffin et al., 2008). 
A non-union however, is established when a biological bone healing process fails 
completely. In this case, interventions beyond standard fracture fixation become 
necessary (Griffin et al., 2008).  
  
According to their radiographic appearance, non- unions are classified as: 
-      hypertrophic, which develop abundant callus without achieving adequate stability. 
They are caused by a mechanical failure. 
-      atrophic, characterized by little to no callus formation and signs of bone resorption. 
They are caused by a biological failure (Griffin et al., 2011). 
Delayed unions and non- unions are associated with substantial morbidity and pain, 
which significantly reduce the quality of life of patients and causes prolonged 
convalescence. 
The economic impact is enormous as weeks or even months of inability of affected 
people to work generate extremely high costs, not only associated with amount of not 
working days but also with additional health care and treatments. 
 Critical sized defect and augmentation 
Some fractures are too big to bridge alone and are therefore called critical sized defects. 
The pathogenesis includes severe trauma, developmental deformities, tumor resection or 
osteomyelitis. A critical size defect in bone, by definition, would not heal spontaneously 
or does not exhibit more than 10% regeneration. The size of such defect, in long bones, 
is defined to be larger than 2 to 2.5 times the diameter of the bone (Wang and Yeung, 
2017).  
  
In these cases, an additional material has to be introduced inside the defect to support the 
body in healing. Augmentation materials fulfil at least one of the following functions: 
osteogenic potential (e.g. contain cells), osteoinductivity (contain bone-inducing 
substances), osteoconductivity (scaffold for bone formation) and, in some cases, may 
also provide mechanical stability until bone is rebuilt (McAllister and Haghighat, 2007; 
Wang and Yeung, 2017). 
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Augmenting a defect is a standard and very common procedure, with over two million 
performed worldwide annually (Wang and Yeung, 2017).  
There are several options when it comes to augmentation materials: 
- autografts (harvested and transplanted within the same individual, derived most 
commonly from iliac crest bones), are considered the gold standard as they 
provide most complete and rapid integration  
- allografts (harvested within the same species), the risk factors are: graft viability 
and integration, disease transmission, immunological response and possible 
rejection, as well as limited availability 
- xenografts (harvested within another species), where the main cons are again 
rejection risk and availability 
- alloplasts (synthetic materials like calcium sulfate and calcium phosphate 
compounds), which are not always reliable in their bone regeneration potential. 
Autografts, despite the limited volume of available material, possible donor site 
complications, additional pain, increased operative time and blood loss are still the most 
effective method of bone augmentation.  
 Healing stimulation  
Precisely because of all challenges and problems that need to be overcome during 
fracture healing management, different strategies of additional bone healing stimulation 
have been introduced and widely used for decades. They can be characterized as 
biological and biophysical. 
 Biological methods 
- Local, using osteogenic materials like autologous bone marrow, autologous bone, 
peptide signalling molecules (FGF- 2 and PDGFs), morphogenetic factors 
(BMPs- bone morphogenetic proteins and Wnt proteins) and osteoconductive 
materials (calcium phosphate, calcium hydroxyapatite, calcium sulphates 
amongst others) (Einhorn and Gerstenfeld, 2015; Saliev et al., 2019). In 
particular, BMPs have been extensively investigated and BMP-2 and -7 were also 
approved by the FDA for some clinical uses. For example, BMP-7 can be used as 
a substitute of an autograft in a long bone non-union. It was shown to increase 
healing rates for fractures and wounds and decrease risk of infection. Although 
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their application may cause some controversy, a rapid increase in their use was 
reported in the last decades (Garrison et al., 2010; Glass and Jain, 2013; Nakase 
and Yoshikawa, 2006).  
- Systemic, which are being under investigation as a rather future possibility, for 
example, PTH (parathyroid hormone), humanized monoclonal anti- sclerostin, 
anti- Dickkopf- related protein 1 antibodies (art. 5, 13). PTH is a naturally 
occurring hormone, having a direct impact on mineral homeostasis of the body. 
Several studies proved that PTH treatment increased bone stiffness, mineral 
composition and density (Alkhiary et al., 2005). 
 Biophysical methods 
- Low intensity pulsed ultrasound stimulation, which was shown to accelerate bone 
healing not only during a normal fracture repair process (Heckman et al., 1994) 
but also in the treatment of non-unions (Nolte et al., 2001; Randau et al., 2014). 
Acoustic pressure waves reach a bone, causing low-level micromechanical 
pressure. The healing mechanism is believed to be related to the piezoelectric 
properties of bone and production of mediators like prostaglandin E2. Low 
intensity pulsed ultrasound stimulation has been proven to increase formation of 
the callus, decrease healing time and enhance fracture healing. 




Pulsed electromagnetic field stimulation (PEMF) is a non- invasive, local form of electric 
stimulation of different tissues. This method, due to its biosafety and therapeutic efficacy, 
was used for decades in fracture healing enhancement and acceleration. Furthermore, it 
is convenient and has no described side effects or feeling of discomfort. 
One of the first reports describing positive effects of pulsed electromagnetic field 
stimulation on bone healing appeared already in 1972 by Kraus and Lechner (Kraus and 
Lechner, 1972) and in 1974 by Bassett et al. Since then, this stimulation method was 
widely applied in bone healing and to treat healing complications such as non-unions 
(Bassett et al., 1974). This was followed by an official approval of its clinical use by the 




Electromagnetic field is a combination of electrical and magnetic fields. A magnetic field 
is specified by the direction and the magnitude and is measured in Tesla. Its application 
for bone healing usually ranges from 0.01 to 2 mT and produces electrical fields within 
bone tissue ranging from 1 to 100 mV/cm (Chalidis et al., 2011; Marsell and Einhorn, 
2011; Yuan et al., 2018).  
Such induced voltages are supposed to be similar to those produced naturally during 
dynamic mechanical deformation of different tissues (Bassett, 1993; Bassett et al., 1964). 
This is related to the piezoelectric effect of hydroxyapatite in bone, which is manifested 
in its ability to convert mechanical energy to electrical current, therefore producing 
voltage (Trock, 2000). As a consequence, osteoblasts are stimulated, enhancing mineral 
deposition and increasing bone density. Also, direct electrical stimulation may lead in a 
similar pathway to bone regeneration enhancement (Balmer et al., 2018; Kubo, 2012; 
Noris-Suarez et al., 2007; Otter et al., 1998; Ryaby, 1998; Stroe et al., 2013). 
Pulsing of EMF implies to the repetition of the electromagnetic pulses with a specific 
repetition rate. It is essential to remember that physiological effects are induced only in 
certain parametric “windows” and thresholds (Funk and Monsees, 2006). These windows 
are relating to the field amplitude, duration and frequency of exposure. The ideal 
parameters have not been established so far, but it was observed that a frequency range 
between 1-50 Hz was most effective for humans. The shorter the pulse, the stronger 
induced current is created (Biggane et al., 2016). 
In fact, using parameters outside these windows may result not only in a lack of effects 
but possibly in negative consequences. It was shown, that fresh fractures in rats treated 
with High-intensity Electromagnetic Pulses, exhibited delayed callus formation and 
worse healing progress compared to the control group (Leisner et al., 2002). 
Although the principle of treatments presented in most of the PEMF related studies stays 
the same, the PEMF characteristics greatly differ. Table 1.1 summarizes the designs and 
findings of 15 representative studies using various version of PEMF in vivo. 
Bassett et al. described multiple discrepancies between studies with PEMF, for example, 
heterogeneous treatment regime, dissimilar pulse shape and duration, frequency 
characteristics, amplitude, spatial orientation and intensity among other factors (Bassett, 
1993). These discrepancies and lack of standardization are still observed with recently 
published studies. 
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Midura et al. (Midura et al., 2005) and Fredericks et al. (Fredericks et al., 2000) showed 
a two-fold faster osteotomy healing in PEMF- stimulated rat or rabbit bones. Accelerated 
healing was also exhibited by human patients in multiple other studies (Capanna et al., 
1994; Dhawan et al., 2004; Holmes, 1994; Mammi et al., 1993). Qualitative differences 
were documented by Cane et al. (Cane et al., 1993) and Borsalino et al. (Borsalino et al., 
1988) in favor of treated groups compared to the controls in horses and humans 
respectively.  
It is worth emphasizing that most of these studies exhibit very different treatment patterns 
and designs. The study conducted by Fredericks et al. used treated time as low as 30 
minutes per day, whereas the majority of other studies were designed to use PEMF for 
multiple hours a day, sometimes as much as 12 hours (Sharrard, 1990). The treatments 
usually lasted several weeks,  ranging from 1 week (Ding et al., 2011) to 12 weeks (Betti, 
1999). 
The study models were also extremely varied, counting, among others, fibular osteotomy 
in rats (Midura et al., 2005), metacarpal fracture in horses (Cane et al., 1993), hip 
osteoarthritis in humans (Borsalino et al., 1988), metatarsal non-union in humans (Streit 
et al., 2016) or lumbar fusion in humans (Mooney, 1990). As shown in the table 1.1 , 
device parameters also had wide ranges, with pulse frequencies starting at 1.5 Hz 
(Fredericks et al., 2000) and reaching 75 Hz in the majority of the studies (Borsalino et 
al., 1988; Capanna et al., 1994; Dallari et al., 2009). Some device parameters were not 
reported at all (Streit et al., 2016). Such variety and variability of treatment options makes 
it difficult to notice a standardized trend of data and build upon previously published 
findings. Moreover, the differences in these numerous parameters often result in diverse 
effects. In conclusion, there are only a few well-designed prospective studies available 
and it remains very difficult to draw clear findings and parameter windows from what is 







Device parameters Results (treated group 
compared to the 
control) 
Midura 





3h / day for 5 
weeks 
Physio Stim: 15 kHz, 
5.56 ms, 2mT  
Osteo Stim:  
1.5 Hz, 16ms 
Physio Stim:  2x faster 
healing 
Osteo Stim: not 
effective 
Ding  









4h a day 
for 1-8 weeks 
15 Hz  
4.5 ms  
0-12 G 
Osteonecrosis 
incidence with PEMF 
treatment: 29% 
Control with steroid: 
75%,  Control 
without steroid: 0% 
Fredericks  




108 rabbits  
Gr 1:  
30 min/day 





2x faster healing with 
PEMF 
in 60 min group 
1.3x faster in 30 min 
treated group 
Cane  










1.3 ms  
2.5-3 mT 
  Advanced healing in TI 
Borsalino  









90 days  
75 Hz, 1.3 ms  
2.5 mV 
18 Gauss 
Better healing and 
denser callus in PEMF- 
treated group 
Holmes 






8-10 h a day 
15 Hz 
4.5 ms  
0-20 Gauss 
All healed in 2-8 
months 
Streit 






10h / day 
Not described TI healed in 8.9 weeks 
CI in 14.7 weeks 
Betti 







8h a day, 
90 days 
75 Hz  
1.3 ms  
2.5-3 mT 
TI: 7% not healed CI: 
17.6% not healed  
Necrosis in 28.5% TI 
and 47% CI 
Shi 









8h a day 
Not described Union rates: 
TI: 77.4%  
CI: 48.1% 
Capanna  











1.3 ms  
3.0 mV 
TI: decreased healing 
time 
Dallari  







>6h a day, 
12weeks 
75 Hz  
1.3ms  
2 mT 











Device parameters Results (treated group 
compared to the 
control) 
Dhawan  



















TI accelerated healing 














1.3 ms  
3 mV 
advanced healing in 









min. 8h a day 
1.5 Hz 1.8 Gauss Healing rates: 
CI: 64.9 %  










12 h a day 
12 weeks 
15 Hz 
20 pulses/ burst 
TI: 5/20 union, 5/20 
progress and 10/20 no 
change 
Table 1.1: Representative review of PEMF studies, emphasizing discrepancies between study design as well as 
differences in PEMF device parameters, treatment regime and outcomes. Unless otherwise specified, all studies 
had a control group which was treated like the test group, except for PEMF application. 
 
 PEMF device 
There are two main components building a PEMF therapeutic unit. The first one is a 
generator, which produces an alternating current at a specific frequency and amplitude.  
The second one is a coil, which receives the current and produces pulses of magnetic 
field that stimulate the tissues of the area where it is placed. As a consequence, a 
secondary electrical field is induced and produced in the bone (Bassett, 1993; Leisner et 
al., 2002).  
 PEMF effects on cellular mechanisms 
There are several pathways through which PEMFs can affect cells and tissues. The 
calcium signalling is considered to be the main one as the intracellular calcium is a crucial 
factor in the translation of PEMF signal into biological responses.  
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The PEMF passes through the cell membrane. An electrical field is then induced in the 
cytosol and causes the release of intracellular calcium into the cytosol. Calmodulin is 
activated and bone cell viability is enhanced. 
What is more, intracellular calcium increases nitric oxide levels, followed by an increase 
in cGMP and the activation of protein kinase G. This pathway promotes MSC and 
osteoblast differentiation and maturation and reduces pain through inflammatory 
cytokines such as IL1-Beta. It also influences angiogenesis by increasing the expression 
of FGF-2 and VEGF (Yuan et al., 2018). 
A great range of subcellular and cellular responses to different PEMF forms have been 
documented. In general, this therapeutic method influences bone healing by promoting 
bone formation and suppressing bone resorption. This is achieved by influencing 
numerous processes and reactions that take part in osteo-, chondro- and angiogenesis. 
PEMF has an ability to stimulate cell migration and proliferation, cause changes in cell 
cycle and differentiation, growth factor expression and DNA replication (Saliev et al., 
2019). Moreover, positive local influence on pain reduction is associated with this form 
of therapy (Ryang We et al., 2013).  
Electromagnetic stimulation has many clinically relevant effects described in the 
literature:  
- stimulate osteoblasts to secrete growth factors (e.g. BMP-2 and -4, TGF- beta), 
enhance expression of BMP-2, TGF- beta, osteoprotegerin, osteocalcin, stimulate 
osteoprogenitor cells, enhance the osteogenic effects of BMP-2 on mesenchymal 
cells (Aaron et al., 2004; Chalidis et al., 2011) 
- increase DNA synthesis (Bassett, 1993; Brighton et al., 2001)  
- increase levels of alkaline phosphatase, an early marker of osteogenesis (Saliev 
et al., 2019) 
- increase osteoblastic calcium deposition (Bassett, 1989), enhance extracellular 
matrix protein synthesis and mineralization and cartilage matrix reconstruction 
(Aaron and Ciombor, 1993; Gossling et al., 1992)  
- cause arteriolar vasodilation, accelerate intramedullary angiogenesis (Chalidis et 
al., 2011; Ikegami et al., 2015) 
- limit inflammation by cytokine modulation, e.g. reduce IL-6 concentration 
(Benazzo et al., 2008) 
- effect production of proteins regulating gene transcription  
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- affect membrane receptors (PTH, insulin, IGF-2, calcitonin receptors) 
- activate the mTOR pathway in pre- osteoblasts and fibroblasts 
- improve soft tissue repair (Chalidis et al., 2011) 
As demonstrated, the range of different mechanisms and pathways through which PEMF 
influences processes within the bone is very broad and varied. 
PEMF has been most commonly used as an additional treatment option for delayed 
unions and non-unions, successfully increasing the union rates. Also an early stage 
application has been reported to positively impact fresh fracture healing, substantially 
accelerating this process (Hannemann et al., 2011; Shi et al., 2013). It has also been used 
in treatment of joint or spine fusion, arthrodesis, congenital pseudarthrosis, osteotomy, 
osteoporosis, osteonecrosis, osteochondritis dissecans, osteogenesis imperfecta and 
osteoarthritis (Ding et al., 2011; Marks, 2000; Simonis et al., 2003; Trock et al., 1993; 
Vavken et al., 2009). 
The effect of PEMF application on bone graft incorporation and improvement of 
biomaterial osteointegration (Dallari et al., 2009) has also been described. 
 Animal model 
There are several possibilities when it comes to choosing a right animal model for 
fracture healing research. Nevertheless, there is no perfect one and each of them has its 
up- and downsides. Most commonly used are rabbits and rats as they are easy to maintain 
and to work with, however, the limitation is their small size (Gilsanz et al.,1988) and 
faster healing rates compared to humans. The other possibilities include: sheep, goats, 
pigs, guinea pigs, dogs and horses. 
Sheep have similar bone metabolism as humans and are proven experimental animals for 
studies related to bone formation and defect healing (Martini et al., 2001). 
Based on several studies conducted by MSRU using tibia defects (Bottlang et al., 2016; 
Plecko et al., 2013; Plecko et al., 2012; Richter et al., 2015), it has been demonstrated 
that standardization can be reliably achieved and sheep osteotomy models are appropriate 
for bone healing comparison purposes.  
These studies had group sizes of either six or twelve and used female sheep of average 
age between 2-3 years and homogenous weight distribution (approximately 60-70 kg). 
Non- critical size defects ranging from 0 to 3 mm were created with either transverse or 
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45°angle tibia osteotomies. Sheep received full limb casts applied for the entire in-life 
phase. In some of these studies, animals were kept in suspension nets during first 3 weeks 
post operatively. Radiographic examinations were performed weekly in order to find the 
most optimal time point for sacrifice when differences between groups are largest. The 
sacrifice time point ranged from 6 to 12 weeks after surgery. It is worth mentioning that 
their main aim and focus were novel medical devices themselves (locking plates and 
screws), and not a healing enhancement therapy. 
A sample size of six is relatively low but was successfully used in most of the mentioned 
studies and was proven to provide sufficient data when complication rates are very low. 
Calculating the optimal number of animals used for a trial is one of the most essential 
parts of designing a study. On one hand, too small sample size may not reflect the 
behavior of a population. On the other hand, too big sample sizes, while better 
statistically, leads to unnecessary experimental usage of animals. The sample sizes often 
used in these studies were sometimes only six, however, they were large enough for the 
detection of different effects between groups (Charan and Kantharia, 2013).   
In these studies, some tendencies were observed, and although not statistically 
significant, they showed if the test item had positive healing potential. 
For the purpose of this study, it has been decided that sheep is the most optimal animal 
model, as their size and weight are comparable to humans. Furthermore, the tibial bone 
shows great similarities with the one of humans when it comes to the macroscopic 
appearance and the bone mineral composition. The bone metabolism and remodelling 
properties and the pattern of bone ingrowth into the implants over time are also much 
alike. Sheep are a very reproducible and practical model: they are available, tolerate 
captivity well, are easy to house and handle. They also show good tolerance to surgery 
and resistance to infections and diseases. Although the bone microstructure differs from 
the one of humans and the sheep bone density is significantly higher, the inter-animal 
uniformity and already existing extensive database of biological information greatly 
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 Aim of the thesis 
The aim of this thesis was to evaluate the impact of Marvel technology on bone healing 
in a standardized manner. This technology integrates electromagnetic therapy within a 
bone screw close to the fracture site, in order to enhance bone healing by locally 
amplifying the pulsed electromagnetic field stimulation.  
Two sheep models using Marvel screws positioned across a tibia osteotomy were 
performed: 
- 3 mm gap model: the tibia osteotomy was stabilized using internal fixation, 
leaving a 3 mm gap – a non-critical defect size.  
- 17 mm graft model: a critical size defect of 17 mm was created in the tibia, which 
was stabilized also using internal fixation. The defect was augmented with 
autologous bone grafts (or left empty in a negative control group).  
The effect of the Marvel technology was evaluated radiographically, biomechanically 
and histologically, by analysing fracture healing kinetics, torsional stiffness, callus 




 Materials and Methods 
 Study Design 
All animal experiments were conducted at the Musculoskeletal Research Unit (MSRU), 
Winterthurerstrasse 260, 8057 Zurich, Switzerland according to the Swiss laws of animal 
protection and welfare (Tierschutzverordnung, TVV 455.163 / Tierschutzgesetz, SchG 
455).  
The experiment was authorized by the cantonal ethical committee under the license no. 
ZH183/17.  
For this study, two transverse tibia osteotomy models in sheep were used: 
1. A 3 mm interfragmentary Gap Model 
2. A 17 mm interfragmentary Graft Model  
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The 3 mm gap model experiment contained a Test Item (TI) group and a Control Item 
(CI) group. The 17 mm graft model experiment contained a Test Item (TI) group, a 
Positive Control Item (CI) group and a Negative Control Item (NCI) group (see Table 
2.1). 
14 adult, female, Swiss alpine sheep with an age range between 24-30 months (Ø 28.7 
months) and an average bodyweight of 62.70-76.60 kg (Ø 66.98 kg, at delivery) served 
as experimental animals for the 3mm gap model. While for the 17mm graft model 15 (12 
with autograft, 3 without) adult, female, Swiss alpine sheep with an age range between 
24-34 months (Ø 31.2 months) and an average bodyweight of 58.60-86.65 kg (Ø 72.85 
kg, at delivery) were used. 
To standardize the gap sizes, two custom made cutting guides were used. The bone 
fragments were fixed using standardized internal fixation either with a 12 hole (3mm 
gap) or a 13 hole (17mm gap) broad Locking Compression Plate (LCP) and 3.5mm 
Locking Screws. The two holes next to the gap were left empty (hole 7, 8) to place the 
two Marvel screws perpendicularly to the plate by use of a specially developed Marvel 
drill guide. After placement of the cortical screws from cranially to caudally, Marvel 
transducers with corresponding wire connectors were attached to both screw heads. The 
surgical procedure was the same (same implant placement) for all animals in the 3 mm 
gap model and all animals in the 17 mm graft model, regardless of the group (TI, CI or 
NCI). Indeed, in all animals, two Marvel screws were implanted on either side of the 
















3 mm gap 
model 
Test Item (TI) Yes Yes Yes No 




Test Item (TI) Yes Yes Yes Yes 
Control item (CI) Yes Yes No Yes 
Negative Control (NCI) Yes Yes No No 
Table 2.1: Treatment Group Description. 
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After surgery, the operated limbs of all animals were casted and the animals of the 17 
mm gap were additionally kept in suspension during the first 4 weeks after surgery. 
Operated sheep limbs in the TI group were treated with Pulsed Electromagnetic Field 
Stimulation (PEMF) treatments after surgery (twice daily, 90 mins each, starting 4 days 
post-OP until sacrifice). The CI and NCI group animals received no PEMF treatment, 
but the outer coil was applied nonetheless for the same amount of time (twice daily, 90 
mins each, starting 4 days post-OP until sacrifice). This was done to make sure that the 
sheep in all groups (TI, CI and NCI) use their limbs the same way and carry the same 
load throughout the in-life phase. 
Therefore, in the 3mm gap model, the TI consisted of the Marvel screws connected to 
the implanted transducer as well as the outer coil connected to the power amplifier, which 
delivered the PEMF treatment. The CI in the 3mm gap model consisted of all of the 
above-listed components, except for the connection to the power amplifier (no PEMF 
treatment). For the 17mm graft model, in addition to the list of components above, both 
TI and CI included the autograft material, while the NCI did not (Table 2.1). 
Cast changes and radiographs in three projections (anteroposterior (0°), two angled 
planes: caudal (265°) and cranial (275°)) were performed weekly beginning in week 3 
post-operatively until sacrifice. After 9 weeks of follow up, all sheep of the 3 mm gap 
model were sacrificed, while all animals of the 17 mm gap model were sacrificed after 
12 weeks. After sacrifice, fracture healing was evaluated radiologically (radiographs and 
Micro-CT), biomechanically and histologically.  
Both tibiae of each animal were harvested, cleansed from surrounding tissue, labelled, 
macroscopically examined for hardware failures, screw loosening, tissue reaction, and 
callus formation. Local draining lymph nodes (lnn. poplitei) were harvested and 
macroscopically evaluated. Photographs were taken of representative implant-related 
macroscopic findings and stored digitally. For transport, both tibiae of each sheep were 
wrapped in wet gauzes soaked with saline solution and placed in plastic bags, labeled 
with the sheep number and limb side (left or right).  
The operated and non-operated tibiae were immediately transported to Scanco Medical 
AG for Xtreme CT II scanning. Afterwards they were transported to the Institute for 
Biomechanics ETHZ, Prof. Ferguson, for biomechanical testing. 
After biomechanical testing, the remaining part of the treated tibiae were prepared for 
histological processing. Ground section were cut, and microradiographs were taken 
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before mounting and staining. Histomorphometrical, histological, and fluorescence 
analyses were performed. Afterwards, thin sections were cut, stained and histologically 
evaluated. An overview of analyses and their purposes is presented in the Table 2.2. 
 
 
Analysis Purpose Time points 
Radiographs 
Radiographs of the operated tibia were taken at different 
angles to allow better visualization of the callus formation at 
the cis- and trans-cortex. Radiologic healing was semi-
quantitatively evaluated focusing on callus formation, callus 
and defect density over time. The callus area was 
quantitatively measured using Osirix  
3mm gap 
model: 
Post OP and 
weeks 
3,4,5,6,7,8 and 9 
17mm graft 
model: 
Post OP and 
weeks 3,6,9 ,12 
Fluorescence 
Determination of Calcium deposition, indicative of new bone 
formation at the fracture gap area and surrounding at 
different time points by means of fluorescence marker 
injection  
3 w. post OP: 
calcein green 







Local draining lymph nodes were collected evaluated. callus 














Evaluation performed qualitatively (for type of bone healing, 
predominant cell types, vessel formation) and quantitatively 




Table 2.2: Overview of analyses and their purposes. 
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Figure 2.2: Timeline and evaluation methods for 17mm graft model. 
 
 
Experiment Treatment Group Number of Sheep Operated Limb (L:R) 
3 mm gap model 
Test Item (TI) 8 4 : 4 
Control Item (CI) 6 3 : 3 
17 mm graft model 
Test Item (TI) 6 3 : 3 
Control Item (CI) 6 3 : 3 
Negative Control (NCI) 3 2 : 1 












































90 min PEMF Treatments 2x / day
Day 4
4 w suspension
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Experiment Treatment Group Average age in months Average weight in kg 
3 mm gap model 
Test Item (TI) 30.5 ± 2.9 67.4 ± 2.8 
Control Item (CI) 32.0 ± 1.1 66.4 ± 4.5 
17 mm graft model 
Test Item (TI) 36.0 ± 1.1 71.8 ± 9.5 
Control Item (CI) 36.0 ± 1.1 73.3 ± 7.5 
Negative Control 
(NCI) 
27 74.0 ± 2.3 
Table 2.4: Group characteristics. 
 
Both the 3 mm model and 17 mm model provide an ideal, standardized situation to 
evaluate bone healing under physiological biomechanical loading. Indeed, standardized 
operating procedure allows the reliable creation of reproducible defects and the secure 
placement of a fixation plate. In addition, sheep have the ideal size for implanting device 
such as the Marvel implants, because devices of the same size would be destined for 
human use.  
 Animal Test System  
 Randomization and Allocation 
Animals were randomly selected by hand and allocated to treatment groups. The operated 
hind limb was alternated from one sheep to the next to ensure an equal distribution within 
the groups. 
Animal husbandry conformed to the Swiss requirements. Community tap water from the 
city of Zurich was available ad libitum. Hay and mineral supplements were provided ad 
libitum. The animals were fasted at least 24 hours before anesthesia but were allowed 
access to water ad libitum.  
There was daylight cycle and environmental conditions were continuously monitored for 
temperature and humidity. Occasionally rise of temperature and humidity occurred, 
usually following room cleaning or other reasons and are considered not to have any 
influence on this type of study. 
During acclimatization, sheep were housed in group pens (“Strickhof”: YUS-D-11). 
After surgery, sheep were moved to smaller, single boxes (“Minipig 1”: YMP-E-4 or 
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“Minipig 2": YMP-E-5), where they could still maintain eye and nose contact to other 
sheep. Housing pens always provided at least 2 m2 per animal.  
The first three control animals (86.04, 86.05, 86.06) were kept together in a bigger box 
(“Minipig 1”: YMP-E-4) from the tenth day post-surgery. They were in group as there 
were no cables attached to the coils during the treatment time, however, to ensure no bias 
between the groups, these control animals were also put in small individual boxes after 
about three and a half weeks. In this way, all sheep had the same movement possibility.  
 Experimental procedure 
 Anesthesia 
Standardized anesthesia was performed and anesthesia health checks were performed as 
a general check of cardiovascular and respiratory function prior to sedation as well as 
prior to induction of anesthesia. 
After 16 to 24 hours of fasting and 30 minutes before induction of anesthesia, the animals 
were premedicated with buprenorphine (0.01 mg/kg BW im, Temgesic®, Reckitt 
Benckiser AG, Wallisellen, Schweiz) and either xylazine (0.1 mg/kg BW im, Xylazin 
Streuli ad us. vet., Streuli Pharma AG, Uznach, Schweiz, animals 86.01-86.07) or 
medetomidine (0.005-0.01 mg/kg BW im, Medetor®, Virbac AG, Opfikon, Schweiz, 
animals 86.08-86.29). A catheter was placed into one jugular vein and prophylactic 
antibiotics (penicillin 30’000 IU/kg BW iv, Penicillin natrium Streuli ad us vet, Streuli 
Pharma AG, Uznach, Schweiz; gentamicin 4 mg/kg BW iv, Vetagent® ad us. vet., MSTD 
Animal Health GmbH, Luzern, Schweiz), as well as a pre-emptive analgesic drug, 
carprofen (4 mg/kg BW iv, Rimadyl®, Zoetis Schweiz GmbH, Zürich) were given 
intravenously. A booster for tetanus (3’000 IU/sheep sc, Tetanus Serum Intervet, MSTD 
Animal Health GmbH, Luzern) was administered subcutaneously. 
Anesthesia was induced with midazolam (0.1 mg/kg BW iv, Midazolam Sintetica, 
Sintetica AG, Mendrisio, Schweiz), ketamine (3-5 mg/kg BW iv, Ketanarkon® 100 ad 
us. vet., Streuli Pharma AG, Uznach, Schweiz) and propofol (0.4-0.6 mg/kg BW iv, or 
more if needed, Propofol 1% MCT Fresenius, Fresenius Kabi AG, Oberdorf, Schweiz), 
the latter administered to effect. After laryngeal desensitization with lidocaine spray, the 
trachea was intubated and correct placement was confirmed by expired carbon dioxide 
monitoring (FetCO2).  
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Anesthesia was maintained with a balanced anesthetic protocol, employing the 
administration of isoflurane (1%–3%, Attane™, Isoflurane ad us. vet., Provet AG, 
Lyssach, Schweiz) in oxygen via an adult F-circuit, a variable rate infusion of propofol 
(1 mg/kg/h) and ketamine (1.2 mg/kg/h). The cornea was protected with ophthalmic 
ointment. Intraoperatively, Ringer’s lactate solution was administered at a rate of 5-10 
mL/kg/h. 
Monitoring parameters included: electrocardiogram (ECG), heart rate, pulse rate and 
invasively or non-invasively measured blood pressures (systolic, mean and diastolic 
arterial) via an arterial catheter in an auricular artery. Furthermore, inspired and expired 
concentrations of carbon dioxide, oxygen and isoflurane, as well as esophageal 
temperature and saturation of arterial blood (SpO2) was monitored. All parameters were 
constantly measured and recorded in 10-minute intervals. 
 Surgical procedure 
Unless otherwise noted, all mentioned surgical instrumentation and implants were from 
DePuy Synthes®.  
 
Figure 2.3: Surgical set. 
 Presurgical preparation and surgical access (both models):  
The anesthetized sheep were placed in lateral recumbency with the upper hind limb in 
flexion and retracted craniodorsally fixed to the surgery table. The lower hind limb was 
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exposed on its medial side up to above the stifle joint. The limb was firmly supported 
through an inflatable table-mat routinely used during surgeries. 
The entire operated limb was clipped prior to surgery and the surgical site scrubbed and 
cleansed according to surgical routine with the limb in suspension. The animals were 
draped according to routine, where the limb was draped separately, such that it could be 
moved during surgery without jeopardizing sterility.  
An approximate 16-18 cm incision was performed at the medial aspect of the tibia shaft 
extending from the tarsus to the metaphysis of the proximal tibia. Bleeding was 
controlled with electrocautery. The soft tissue and fascia were incised and dissected down 
to the bone. At the proximal end of the tibia, the muscles at the caudal aspect was slightly 
incised at their insertion to the bone and retracted caudally, exposing the full tibia shaft. 
 Procedure for 3mm Gap Model: 
Figure 2.4: Procedure for 3mm gap model. 
A 12-hole, broad, straight veterinary 3.5 mm locking compression plate (VP4045.12, 
length 159 mm, stainless steel) was adapted to the medial aspect of the tibia shaft with 
the most distal hole about 1 cm above the tibiotarsal joint. The plate was slightly 
contoured to fit the tibial shaft. A special developed cutting guide, with 4 rubber rings in 
place (2 proximal, 2 distal), was temporarily fixed to the bone using 2.0 drill guides and 
k-wires (2.0*150mm; 292.200.01) at both ends. 
Using 2.0mm LCP drill guides and a 2.0mm LCP drill (310.534), the cutting guide was 
temporarily fixed to the intact tibia with four monocortical Ø2.7/3.5mm screws (L20 
mm, steel, 202.920), two proximal and two distal, starting with screw position 9&6, 
thereafter 10&5). 
An oscillating saw (saw blade 519.150) was used to perform the osteotomy through the 
guiding slot under constant irrigation with 0.9% saline solution. After removal of the 
cutting guide, the fragments were repositioned and fixed with the 12-hole LCP, utilizing 





1 2 3 4 5 6 7 8 9 10 11 12 
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The already drilled holes were fixed again using the monocortical screws, starting with 
screw position 9 and 6 followed by 10 and 5. Afterwards screw positions 4, 11, 3 were 
drilled bicortically using a 2.8 drill guide with a 2.8 mm drill bit (310.284) and 3.5-mm 
bicortical screws (213.028 - 213.036) in measured lengths were implanted. The k-wires 
were removed and holes 12 and 2 were drilled and screws implanted. Afterwards the 
monocortical screws were removed step by step in an alternating fashion and replaced 




Figure 2.5 (A, B, C, D): Most important surgical steps for the 3mm gap model: Cutting guide fixed with 2 k-
wires and 4 monocortical screws (A), Plate fixed with bicortical screws, 7.+8. left empty (B), Drilling guide for 
Marvel screws fixed on plate (C), Marvel technology implantation and resistance measurement (D). 
 
 Procedure for 17mm Gap Model: 
Figure 2.6: Procedure for 17mm graft model. 
A 13-hole broad, straight veterinary 3.5 mm locking compression plate (VP4045.13, Vet 
LCP 3.5, straight, broad, 13 holes, length 172 mm, stainless steel) was adapted to the 
medial aspect of the tibia shaft with the most distal hole about 1 cm above the tibiotarsal 
joint. The plate was slightly contoured to fit the tibial shaft. A special developed cutting 
17 mm 
distproximal 
1 2 3 4 5 6 7 8 9 10 11 12 0 
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guide, with 4 rubber rings in place (2 proximal, 2 distal), was temporarily fixed to the 
bone with Kirschner wires (2.0*150mm; 292.200.01) at both ends. 
Using 2.0mm LCP drill guides and a 2.0mm LCP drill (310.534), the cutting guide was 
temporarily fixed to the intact tibia with four monocortical Ø2.7/3.5mm screws (L20 
mm, steel, 202.920) two proximal and two distal, starting with screw position 9 and 6, 
thereafter 10 and 5). 
An oscillating saw (saw blade 519.150) was used to perform the osteotomy through the 
guiding slots under constant irrigation with 0.9% saline solution. After removal of the 
cutting guide, the fragments were repositioned and fixed with the 13-hole LCP, utilizing 
the 17-mm distance holder to ensure a standardized parallel gap.  
The already drilled holes were fixed again using the monocortical screws starting with 
screw position 9 and 6 followed by 10 and 5. Afterwards screw positions 4, 11, 3 were 
drilled bicortically using a 2.8 drill guide with a 2.8 mm drill bit (310.284) and 3.5-mm 
screws (213.028 - 213.036) in measured lengths were implanted. The k-wires were 
removed and holes 12, 2 and 1 were drilled and screws implanted. 
Afterwards the monocortical screws were removed step by step in an alternating fashion 
and replaced by bicortically placed 3.5mm screws in measured lengths. 
All screws were tightened again using a torque limiter of 1.5 Nm (511.773) in the first 
6/12 animal (86.01 - 86.06). In all other animals, the screws were tightened with a normal 
screw driver (314.030) until they were firmly locked as detected by the surgeon. Screw 
holes 1, 7 and 8 were left empty. 
 
 
Figure 2.7 (A, B, C, D):  Most important surgical steps for the 17mm Graft Model: LCP fixed with bicortical 
screws with 17mm spacer placed in the gap (A), Marvel screws in place (B), Transducer in place, caps attached, 
autograft filling the defect, cranial view (C), Autograft inside the gap, caudal view (D). 
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 Marvel technology placement and closure (both models):  
After fixation of the plate and retightening of the LCP screws, the rubber rings were cut 
and removed. The Marvel drill guide base was placed to the two remaining LCP holes 
(Nr.7+8) in the middle of the VET plate to assure a perpendicular drilling of the drill 
holes. 
To drill the cortex holes for the Marvel screws, a Ø2.5mm drill guide was attached to the 
drill guide base and the two holes (proximally and distally of the gap) were drilled bi-
cortically using a 2.5 drill bit and the thread was cut using a taping device. 3.5 mm cortex 
screws (204.020 or 204.022) were inserted in the designated holes. 
The two wire caps of the Universal Transducer SI-ES (Magnetodyn® Technology) were 
attached to both hexagonal cortical screw heads (Marvel screws). The wire was looped 
to allow for movement of the wire during the healing period. The transducer was 
positioned under muscle tissue distally. In sheep 86.13 to 86.29, re-worked transducer 
caps were used in order to avoid cap loosening. Specifically, the transducer cap cone was 
widened by 0.2 mm then the cone void was filled with non-elastic epoxy resin and the 
taper was additionally grid blasted. 
The resistance of the transducer was measured using an ohmmeter to verify that the 
handling and implantation procedure did not damage the transducer. A value of 90±15 
Ohms was indicative of a functioning transducer. 
Routine closure of muscle, fascia, subcutaneous tissue and skin was performed. 
Radiographs in 3 different planes (anteroposterior (0°) and two angled planes: cranial 
(275°) and caudal (265°)) were taken immediately after surgery with the animals still 
under anesthesia. A full cast was applied to the operated limb. The animals were 
recovered from anesthesia and observed for bloating, respiratory problems and any signs 
of discomfort or pain until they could eat, drink and stand normally. 
 Casting and suspension 
All operated limbs received a cast for the duration of the in-life period, with cast changes 
performed at each radiographic time point (see Figure 2.1 and Figure 2.2). 
The first full limb cast was applied after the surgery, still in general anesthesia, when a 
radiographic examination confirmed optimal placement of the implants and the Marvel 
technology components. Subsequent cast changes were performed after each 
radiographic examination, without a use of any sedation. 
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Animals of the 17 mm graft model were, in addition, kept in suspension during the first 
4 weeks after surgery, to decrease the risk of postoperative tibia fracture or implant 
breakage. Casting the hindlimbs alone minimizes this risk substantially, however, some 
uncontrolled movements still occur, especially when the sheep tries to get up. The 
suspension excludes this risk almost completely as animals are able to support 
themselves inside it, without exerting high forces on the postoperative limbs. In case of 
skin irritation caused by the suspension nets, they would be additionally padded or 
repositioned. 
Animals with the 3 mm gap did not receive the suspension nets, as it had been proven 
in the previously conducted experimental trials (Bottlang et al. 2010; Plecko et al. 
2012; Plecko et al. 2013; Bottlang et al. 2016), that this precaution method was not 
necessary for the non- critical size defects as the gap would likely heal before the plate 
bends. 
Both casts and suspension systems were checked at least twice daily, to ensure optimal 
comfort of the animals. Neither suspension systems nor casts were interfering with the 
placement of the belts for the Marvel coils or the administration of the PEMF treatment. 
 
Figure 2.8: Casted sheep in the suspension system. 
 Postoperative routine analgesia  
Buprenorphine (0.01 mg/kg BW, im, Temgesic®, Reckitt Benckiser AG, Wallisellen, 
Schweiz) was applied as pre-emptive analgesia and additional sedative 30-45 minutes 
before induction of anesthesia and every 4-6 hours after recovery on the day of surgery 
and as deemed necessary for up to three days after surgery depending on pain assessment. 
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Carprofen (4 mg/kg BW, SID, iv, Rimadyl®, Zoetis Schweiz GmbH, Zürich) was given 
as pre-emptive analgesia prior to induction of anesthesia and for five days after surgery 
depending on pain assessment.  
Paracetamol (10mg/kg BW, iv, BID, Paracetamol Fresenius, Fresenius Kabi AG) was 
given to the animals of the 17 mm graft Model postoperatively as deemed necessary, 
BID-TID every 8 – 12 h for 3-4 days. 
 Prophylactic antibiotic therapy 
Prophylactic antibiotic therapy was administered for five days starting on the day of 
surgery: penicillin (30’000 IU/kg BW, BID, iv, Penicillin natrium Streuli ad us vet, 
Streuli Pharma AG, Uznach, Schweiz)) and gentamycin (4mg/kg/BW, SID, iv, 
Vetagent® ad us. vet., MSTD Animal Health GmbH, Luzern, Schweiz). 
A booster for tetanus (3’000 IU/sheep sc, Tetanus Serum Intervet, MSTD Animal Health 
GmbH, Luzern) was administered subcutaneously on the day of surgery. 
 In-life observations 
All in-life observations and examinations of the animals were performed by 
veterinarians, veterinary engineers or special trained animal caretakers under supervision 
following standardized operating procedure. Medical records were kept for each animal, 
and the observations listed below recorded.  
A first general health check was performed by a veterinarian on the day of arrival to the 
MSRU. Also during the acclimatization period all animals were observed several times 
a day for any signs of abnormalities. A blood sample for hematological and chemical 
examination was taken from every sheep and checked by a veterinarian. Only healthy 
sheep were included in the study. The animals were weighed once prior to surgery during 
the acclimatization period for the exact medication dosage calculation. 
General health check of cardiovascular and respiratory function was performed prior to 
sedation and prior to induction of general anesthesia. All sheep received a study specific 
ear tag and a subcutaneous transponder for identification purposes during the general 
anesthesia. 
During the postoperative observation period all animals were checked at least twice daily. 
Any signs of pain, lameness, discomfort or loss of appetite were documented in the 
medical records. 
After the surgery was completed, the animals were transported to their single boxes  
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and examined at least three times in the first two hours after surgery, until normal  
behavior and clinical parameters were restored. Hay was provided at least twice daily, 
with the exception of the day of cast change, when the animals were fasted for at least 12 
hours to prevent bloating and the day prior to surgery, when the animals had to be fasted 
for 24 hours. Water was provided ad libitum. 
Environmental conditions were continuously monitored using a data logger for 
temperature and humidity (temperature range 10-35°C, relative humidity range 10-95%). 
There was daylight cycle. 
 Pulsed electromagnetic field therapy 
All sheep in the study were fitted with the Marvel outer coil (Figure 2.9 and Figure 2.10) 
for 90 mins, twice per day, for the duration of the in-life period, starting at day 4 after 
surgery. Custom straps were designed to allow ease of handling, ensuring sheep would 
be minimally disturbed without compromising the animal's ambulation. The straps were 
also designed to distribute the weight of the coil on the lower back of the sheep. The 
outer coil was custom shaped to fit a casted sheep hindlimb. Sheep in the test groups of 
both the 3 mm gap model and the 17 mm graft model had their outer coils connected to 
the PEMF generators. These generators were designed to create a 5 mT alternating 
magnetic field inside the outer coil (flux density of 3-5 mT and a frequency of 12-20 Hz). 
This magnetic field creates up to 700mV electrical potential within the internal 
transducer thereby delivering an electromagnetic therapy between the two implanted 
Marvel screws, which act as electrodes across the tibia defect.  
The first treatment always started in the morning, around 8 AM, ended therefore at 9.30 
AM. The afternoon treatment would typically start around 2 PM and end at 3.30 PM. The 
average time between both treatments was 5 hours 18 minutes. There were, however, 
situations with both shorter and longer breaks between the morning and afternoon 
treatments, especially on days when radiographs and cast changes were planned.  
There were some situations when treatment was interrupted, for instance, because of 
excessive movement of the animal inside the box or by stepping on the cable connecting 
the coil to the generator. In such cases, the cause of the interruption was resolved if 
possible (e.g. shortening or extending the length of the cable, checking if the machine 
works properly) and the treatment was resumed. 
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Figure 2.9: Pictures of sheep fitted with the Marvel outer coil. 
 
 
Figure 2.10: Closer picture of the Marvel outer coil and straps attached to it  
during the pre- surgical coil fitting. 
 
 Radiographic follow-up 
Radiographs were taken immediately after surgery with the animals still under anesthesia 
in three different planes: anteroposterior: 0°, two angled planes: 275° (anterior, cranial) 
and 265° (posterior, caudal). All radiographs were performed at 50 kV and 2.0 mAs. 
The anteroposterior projection was used for the exact gap area evaluation, as the position 
of the plate, screws and the Marvel technology components allow for a clear undisturbed 
view of the defect. It also shows the callus formation at both cis and the trans cortices. 
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The angled projections were used for the evaluation of the healing progression on the 
cranial and caudal tibia cortices. Additionally, these projections would make it possible 
to detect any caps loosening or detachments.  
Starting three weeks post-surgery, radiographs were taken in the same planes as 
postoperatively during cast changes: 
• 3 mm Gap Model: 
During In-life phase: 3, 4, 5, 6, 7, and 8 weeks 
Post mortem: 9 weeks  
• 17 mm Graft Model: 
During In-life phase: 3, 6, 9 weeks 
Post mortem: 12 weeks 
 
                                 
Figure 2.11 (A, B, C): Example of the three radiographic projections: anteroposterior: 0° (A), oblique 275° 
(anterior, cranial) (B) and oblique 265° (posterior, caudal) (C) of sheep 86.28 at week 6 post OP.  
 
A C B 
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 Fluorescent marker injections 
Fluorescent dyes were injected at different time points post-surgery. The dyes were given 
in order to document new bone formation at different time points. They first irreversibly 
bind to the calcium in blood and then are incorporated in the bone, thereby documenting 
new bone deposition and remodeling at various stages of healing. This deposition 
happens normally within 48 hours of dye injection, therefore, the dyes were given 2 to 3 
days before the planned calcium deposition timepoint. Three different dyes were used at 
three timepoints as follows: 
3 weeks post-surgery:   Calcein green; 5 mg/kg BW, sc 
6 weeks post-surgery:  Xylenol orange; 90mg/kg BW, sc 
48-72h prior to sacrifice:   Oxytetracycline; 20 mg/kg BW, sc 
The oxytetracycline injection was therefore performed at 9 weeks for the 3mm gap model 
and at 12 weeks for the 17mm graft model. 
Solutions of calcein green (0.5%) and xylenol orange (9%) were freshly prepared in the 
laboratory while commercially available oxytetracycline (Engemycin 10%, MSD 
Animal Health GmbH, Luzern) was used as delivered. The weight from before the 
surgery was used for the dosage approximation. Shortly before the application, the dyes 
were put at room temperature to prevent an unpleasant sensation in the animals. The dyes 
were injected subcutaneously in four different application regions so that no higher 
volume than 20 ml was deposited in one region. 
 Sacrifice, tissue harvest and processing 
Animals were slaughtered according to the Swiss law of animal welfare. A captive bolt 
gun was used for the stunning procedure, providing instant unconsciousness and 
causing the animal to collapse. After stunning was verified by negative response of eye 
reflexes, main blood vessels of the neck were cut, causing exsanguination of the  
animal. 
Tissue harvest after sacrifice: 
After sacrifice, both limbs were harvested and immediately labelled. Radiographs of the 
operated limbs were taken in three projections: anteroposterior at 0° and two angled 
planes at 265° and 275°. 
Local draining lymph nodes (lnn. poplitei) were harvested, photographed and 
macroscopically examined. Changes in lymph nodes were recorded using the following 
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parameters: size, color, consistency, and any other observations, as appropriate. The 
lymph nodes were then fixed and stored in a 4% buffered formalin solution. Further 
processing and histological evaluation were not performed for this study. 
Both tibiae of each animal were cleaned from surrounding tissue and labeled with the 
sheep number and limb side (left or right). A macroscopic examination (see 3.12.1) of 
the implantation sites and surrounding tissue was conducted. Digital pictures were taken 
of the operated tibiae in all planes. Non-operated tibiae from the negative control group 
(86.25 R, 86.26 L, 86.27 R) were not harvested. The resistance of the implanted 
transducer was measured at the caps using an ohmmeter.  
Afterwards screws and plate were removed and stored in plastic bags labelled with the 
study number and animal number. Thereafter, digital pictures were taken in all planes 
without implants. Representative implant-related macroscopic findings were 
photographed.  Both tibiae of each sheep were wrapped in saline soaked gauze and placed 
in plastic bags for transport, labeled with the sheep number and limb side (left or right).  
All harvested tibiae (operated and non-operated) were immediately transported (same 
conditions see above) to Scanco Medical AG for µ-CT scanning. After µ-CT scanning, 
tibiae were transported (same conditions see above) to the Institute for Biomechanics 
ETHZ for immediately biomechanical testing. Operated tibiae from the negative control 
group (86.25 L, 86.26 R, 86.27 L) did not undergo biomechanical testing and were 
transported directly to the MSRU after µ-CT scanning for histological processing. After 
biomechanical testing, non-operated tibiae were discarded and operated tibiae were 
transported (same conditions see above) to the MSRU for histological processing.  
 Micro-CT scanning  
All operated and non-operated tibiae from the TI and CI groups of both models were sent 
to Scanco Medical AG for Micro-CT scanning (52 tibiae in total). Only the operated 
tibiae from the NCI group of the 17mm graft model were scanned (3 tibiae in total), as 
the non-operated contralateral tibiae were not harvested in these animals. The scans were 
performed using an XtremeCT II scanner, operating with an X-ray tube with 60.7 µm 
resolution and 68 kVp voltage. The region of interest for scanning was defined and a 
distance of at least 150 mm was scanned. 
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Figure 2.12: Scanned region of interest are indicated between the two green horizontal lines in the operated 
(left panel) and non-operated (right panel) tibia. 
 
 Biomechanical testing 
In total, 26 pairs of sheep tibiae (operated and non-operated) were biomechanically tested 
at the Institute of Biomechanics of ETHZ. All mechanical torque tests were performed 
using an Instron® E10000 electrodynamic testing machine, following a standardized test 
protocol.  
Biomechanical testing was always proceeded by careful preparations of the samples. To 
prevent slipping of the bone, several steps were undertaken. First of all, periosteum and 
all remaining soft tissue were removed from the potted area. Secondly, four screws were 
inserted perpendicular to the major bone axis in the distal epiphyses, providing further 
stabilization. Wet gauze was placed around the fracture area to ensure proper tissue 
preservation.  
The proximal epiphysis was potted first, while the bone was aligned having both ends 
centered on the mechanical rotation axis. Alignment was maintained with a rigid metal 
bar joining the proximal and distal pot. Potting depth was adjusted to ensure a minimal 
distance of 10 mm between the Beracryl and the nearest screw hole from the fracture 
plate. The spacing between the proximal and distal Beracryl surface after embedding was 
noted and ranged between 140 mm and 160 mm, depending on the tibia length, but 
ideally as similar as possible for each individual.  
–
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Experiment Group 
OP Limb Distance  
between the pots 
 in mm:  
Contralateral limb 
Distance between 
the pots in mm: 
3 mm gap 
model 
Test Item (TI) 153.0 ± 10.8 153.0 ± 10.1 
Control Item (CI) 144.5 ± 11.1 145.1 ± 6.1 
17 mm graft 
model 
Test Item (TI) 146.7 ± 8.9 148.2 ± 10.4 
Control item (CI) 154.8 ± 11.1 154.2 ± 10.6 
Table 2.5: Distance between the pots of both limbs in all groups. 
 
 
Figure 2.13 (A, B, C, D): Tibia preparation for embedding, inserting four screws perpendicular to the major 
bone axis in the distal epiphysis (A) and aligning the proximal epiphysis in the first pot (B). Beracryl embedding 
with alignment of both joints centered in the mechanical rotation axis (C). Embedded tibia installed on the 
Instron® E10000 (D).  
 
Non-destructive torque testing was performed according the following protocol: 
1. Manually load sample with a 5 N axial load 
2. Hold 5 N (axial) for the entire test 
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4. Stop the internal rotation when torque reaches 10 Nm 
5. External rotation back to initial sample position at 5 degree/s to allow sample 
removal 
Rotation (in degrees) and torque (in Nm) were recorded during the torque test at a 
sampling rate of 20 Hz. The test was run in angle control until the end detection of 10 
Nm was reached. The test was manually stopped for samples not reaching 10 Nm after 
12 degrees of internal rotation. 
 
 Histology Processing  
In all operated tibiae, the proximal and distal ends were cut and discarded and the 
remaining part of the operated tibiae were separately placed in plastic molds, labelled 
and fixed in 40% ethanol for at least 1 week, followed by a series of ethanol dehydration 
(50 to 100%): 
• 3x2 days in 50% ethanol 
• 2x2 days in 70% ethanol 
• 2x2 days in 80% ethanol 
• 2x2 days in 90% ethanol 
• 2x2 days in 96% ethanol 
• 4x2 days in 100 % ethanol 
• 2x3 days in xylol as an intermedium to MMA (Methylmethacrylate). 
After complete dehydration, all samples were degreased in xylene and subsequently 
infiltrated in liquid methylmethacrylate (MMA). Polymerization was carried out in 
plastic molds closed with a lid that were kept at 4°C for at least 2 weeks, thereafter in a 
water bath at room temperature until polymerization occurs. Finally, the plastic molds 
were placed in an uncovered incubator (37°C) to complete hardening of the samples. The 
whole process took at least 4 weeks until the tibia blocks were fully polymerized and 
ready to cut.  
The polymerized bone blocks were cut lengthwise (longitudinally) to the screw axis in 
the midline of the bone sample using an Exact® 310 saw. These non-decalcified samples 
were used for histomorphometrical and fluorescence analysis. Therefore, about 1000 µm 
ground sections were cut.  
Materials and Methods 
   47 
Microradiographs of all performed ground sections were taken prior to mounting the 
slices on Acropal slides and surface staining.  
Toluidine blue was used as a surface staining of the ground sections and the bone healing 
response was qualitatively and semi-quantitatively assessed as described in the analysis 
sections (2.12.5 Histomorphometry and 2.12.7.2 Assessment of bone activity, tissue 
character and healing response in the gap areaHistomorphometry). 
After preparation of ground sections, the remaining samples were taken for preparation 
of thin sections (5µm) which were cut with a precision rotary microtome (Leica 
RM2155). The exact area of interest was manually chosen so that it included the defect 
area and both Marvel screws. The 3mm model gap was small enough to present the whole 
area of interest on a single slice. The 17 mm gap model had to be divided in two areas: 
proximal Marvel screw plus the defect and distal Marvel screw plus the defect. Thin 
sections were stained with toluidine blue, van Kossa/ McNeal and HE staining according 
to routine and used for histology evaluation on cellular level and the evaluation was 
focused on the cellular reactions of the tissue (see 2.12.7 Histological Evaluation). 
 
 Analysis 
 Macroscopic Evaluation at sacrifice 
Macroscopic evaluation of the whole tibia, implantation sites and surrounding tissue was 
conducted and pictures of the region of interest were taken.  
The macroscopic evaluation included such parameters like plate appearance and screw 
displacement, presence of callus/ossification around the implants, fibrosis around the 
screw hole or metallosis. Regarding the Marvel technology, following parameters were 
checked: screw integration, placement of transducer and caps, appearance of the 
surrounding tissue. Resistance of the implanted transducer was measured and noted. 
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Figure 2.14: Macroscopic evaluation sheet. 
 
 Micro-CT analysis  
The global morphometry analysis of Micro-CT scans from both operated and non-
operated limbs was performed at the Mechanical Engineering and Mechanics 
Department at Lehigh University.  
In order to create 3D surface models a “slice-by-slice” tissue segmentation was done. 
This method is highly reliable and used to separate the new callus tissue (including 
mature, highly mineralized callus) from the existing cortical bone. Regions of new tissue 
were manually selected within each slice, proceeding by a recombination of these slices 

















   

























































































































































□ 0   □ +   □ ++ 
□ 0   □ +   □ ++ 
□ 0   □ +   □ ++ 
□ 0   □ +   □ ++ 
Clip in place:□ 
yes  □ no  
Loosening: 
□ yes  □ no
Clip in place:□ 
yes  □ no  
Loosening: 
□ yes  □ no
□ 0   □ +   □ ++ 
□ 0   □ +   □ ++ 
□ 0   □ +   □ ++ 
□ 0   □ +   □ ++ 






































Tissue around the 
screw: 




























































































































































Materials and Methods 
   49 
 
Figure 2.15 (A, B, C): CT morphometry transverse sections: original scan (A), selected new bone and old bone 




Figure 2.16 (A, B): Micro-CT morphometry cross sections segmentation: new bone (A), old bone (B). 
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 Biomechanical analysis 
The slope of the linear part of the loading curve (above 6 Nm for most samples) was 
calculated to determine the torsional stiffness (in Nm). This was done for both operated 
and non- operated limbs, where the healthy bones served as references. All loading 
curves were checked at the Institute of Biomechanics of ETHZ, to ensure the correct 
selection of the linear part of the curve. 
The normalized stiffness results were reported as % of contralateral tibia stiffness. The 
comparison of the mechanical performance of the TI and CI specimens was performed. 
 Radiographic Evaluation 
 Semiquantitative Scoring of radiographs 
Interpretation of radiographs was performed by two independent, board certified 
reviewers (Prof. Brigitte von Rechenberg, Dipl. ECVS and Prof. Mark Flückiger, Dipl. 
ECVR). Semiquantitative scores were given following a scoring system specifically 
adapted for this study (Table 2.6). Two additional parameters were evaluated (Table 2.7) 
but not included in the total score. 
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Cortical Callus Formation (0°, anteroposterior plane) 
0 no callus noted 
1 callus not reaching into the defect 
2 callus bridging the defect < 50% 
3 callus bridging the defect >50% but <100 % 
4 callus bridging the defect completely 
Cis-Cortex Callus Formation (0°, anteroposterior plane) 
0 no callus noted 
1 callus not reaching into the defect 
2 callus reaching into the defect, fracture line in callus visible 
3 callus reaching into the defect, fracture line in callus less visible 
4 callus reaching into the defect, fracture line in callus not visible 
Trans-Cortex Callus Formation (0°, anteroposterior plane) 
0 no callus noted 
1 callus not reaching into the defect 
2 callus reaching into the defect, fracture line in callus visible 
3 callus reaching into the defect, fracture line in callus less visible 
4 callus reaching into the defect, fracture line in callus not visible 
RUST Score (0°, anteroposterior plane) 
1 a) fracture with fracture line and no callus formation  
 
2 b) fracture with callus formation and a fracture line  
 
3 
c) fracture with bridging callus, but the fracture line is still visible across both 
cortices 
 
4 d) complete bridging of the callus with no evidence of fracture line 
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Callus Opacity (0°, anteroposterior plane) 
0 soft tissue opacity  
1 < 50% of normal 
2 > 50-100% of normal 
3 > 100% (superimposition)  
Defect Opacity (0°, anteroposterior plane) 
0 soft tissue opacity  
1 < 50% of normal  
2 > 50-100% of normal  
3 > 100% (superimposition)  
Cranial Cortical Gap (275° angled plane) 
0 no callus noted 
1 callus not reaching into the defect 
2 callus reaching into the defect, fracture line in gap visible 
3 callus reaching into the defect, fracture line in gap less visible 
4 callus reaching into the defect, fracture line in gap not visible 
 
Caudal Cortical Gap (265° angled plane) 
0 no callus noted 
1 callus not reaching into the defect 
2 callus reaching into the defect, fracture line in gap visible 
3 callus reaching into the defect, fracture line in gap less visible 
4 callus reaching into the defect, fracture line in gap not visible 
è Total score 0-30 




0 no  
1 yes 
Callus at tip of Marvel screw 
0 no 
1 yes at one screw tip 
2 yes at two screw tips 
Table 2.7: Additionally evaluated radiological parameters. 
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 Histomorphometry 
Microradiographs of all ground sections were taken in order to corroborate the structure 
of calcified tissues in the toluidine blue stained samples. 
Then, quantitative histomorphometric evaluation was conducted using computer-based 
histomorphometric measurements.  
First, ground sections were captured using a microscope (Leica Z6 APOA, Leica DFC 
420C, Glattbrugg, Switzerland) in a standardized magnification (0.5x7.11) as digital 
images in TIF-format. Thereafter, the images were prepared for measurements. The 
tissues of interest were manually color-highlighted interactively using a standardized 
pixel-detecting tool of Adobe Photoshop 12 (Adobe Systems, San Jose, CA).  
 Total section evaluation (3 mm gap model) 
Old bone, new bone and non-bone (non-bone containing tissue like fibrous tissue, fat, 
bone marrow tissue) in the complete (standardized captured) image were color-
highlighted. The region of interest (ROI) was the gap area including both Marvel screws 
up to the 6th and 9th screw in the plate. Following colors were used: 
• old bone: light blue (R: 0; G: 210; B: 255; #00d2ff),  
• new bone: dark green (R: 34; G: 79; B: 7; #224f07) 
• non-bone: pink (R: 242; G: 40; B: 211; #f228d3)  
• background: beige (R: 198; G: 156; B: 96; #c69c60).  
 
Figure 2.17: Animal 86.08, example for total ground section evaluation of the 3 mm gap model. 
Old bone (light blue), new bone (dark green), and non-bone tissue (pink), back-ground (beige), the 
round dots in beige display the Marvel screw areas. 
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 Total section evaluation (17 mm gap model) 
Old bone, callus (containing autograft material within the gap area and newly formed 
bone), non-bone (non-bone containing tissue like fibrous tissue, fat, bone marrow tissue) 
and cartilaginous tissue in the complete (standardized captured) image were color-
highlighted. The callus consisted of newly formed bone and implanted autograft material, 
because the embedded autograft (old bone) and the newly formed bone could not be 
distinguished. The region of interest (ROI) was the gap area including both Marvel 
screws up to the 6th and 9th screw in the plate. Following colors were used: 
• old bone: light blue (R: 0; G: 210; B: 255; #00d2ff),  
• callus: dark green (R: 34; G: 79; B: 7; #224f07) 
• non-bone: pink (R: 242; G: 40; B: 211; #f228d3)  
• cartilaginous tissue: yellow (R: 255, G: 255, B: 0; #ffff00) 
• background: beige (R: 198; G: 156; B: 96; #c69c60). 
 
 
Figure 2.18: Animal 86.13, example for total ground section evaluation of the 17 mm graft model. Old bone 
(light blue), callus (dark green), cartilaginous tissue (yellow) and non-bone tissue (pink), back-ground 
(beige), the round dots in beige display the Marvel screw areas. 
 Sectoral evaluation of callus formation (3 mm and 17 mm gap) 
Callus formation (new bone formation) at the cis cortex, endosteal and at the trans cortex 
were color-highlighted. For the 17 mm graft model, the callus consisted of newly formed 
bone and implanted autograft material, because it could not be distinguished between the 
embedded autograft (old bone) and the newly formed bone. The following colors were 
used: 
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• callus cis cortex: pink (R: 242; G: 40; B: 211; #f228d3) 
• endosteal callus: light blue (R: 0; G: 210; B: 255; #00d2ff),  
• callus trans cortex: dark green (R: 34; G: 79; B: 7; #224f07) 
• rest tissue: beige (R: 198; G: 156; B: 96; #c69c60).  
 
 
Figure 2.19: Animal 86.08, example for sectoral 
ground section evaluation of callus at cis cortex 
(pink), endosteal callus (light blue) and callus at 
trans cortex (dark green), and rest (beige) in the 3 
mm gap model. 
 
Figure 2.20: Animal 86.13, example for sectoral 
ground section evaluation of callus at cis cortex 
(pink), endosteal callus (light blue) and callus at 
trans cortex (dark green), and rest (beige) in the 
17mm graft model. 
 
Afterwards, the colored images were analyzed using a specialized image analysis 
software program (Fiji, ImageJ, version 2.0,0-rc-46/1.50g, build 179d1b4146, date 2016-
03-04, open source image processing software, copyright 2010-2018) and the colored 
fractions were automatically detected and measured in number of pixels.  
The background was excluded from the calculation. All remaining pixels within the area 
of interest were set as 100% and the percentage of new bone formation located at the cis 
and trans cortex as well as endosteal callus were calculated. 
 Fluorescence 
Fluorescent sections were descriptively evaluated for differences of dye integration 
between groups at three different time points (calcein green at 3 weeks, xylenol orange 
at 6 weeks and oxytetracycline (Engemycin 10%, MSD Animal Health GmbH, Luzern) 
prior to sacrifice, either at 9 weeks (3mm model) or 12 weeks (17mm model). Digital 
images of the region of interest (defect area) were recorded. Therefore, 8x8 single images 
were taken in a 1.25 magnification and merged together using a special microscope, 
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camera and specific merging software (Leica LAS-X standard software Leica 
Microscopes, “Stitching function”; Leica DM 6000B, Leica
 
DFC 350 FX, Leica
 
Microsystems CMS GmbH, Mannheim, Germany).  
 
Figure 2.21: Representative sample (86.12, TI) for fluorescence evaluation of the 3 mm gap model, calcein green 
(top left), xylenol orange (top right), oxytetracycline (bottom left), merged image (bottom right). 
 
Figure 2.22: Representative sample (86.18, TI) for fluorescence evaluation of the 17 mm graft model, calcein 
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 Histological Evaluation 
 Assessment of local tissue effects in the Marvel screws area 
Semiquantitative evaluation of biocompatibility parameters (inflammation and tissue 
response), and additional observations (traumatic necrosis, foreign debris) were 
performed according to ISO 10993-Part 6 Annex E (Third edition 01.12.2016) using a 
light microscope (microscope Leica DMR system). The evaluation was performed by 
two independent observers. 
Biocompatibility scoring contained both inflammation and tissue response and was 
separately performed in the implant surrounding area (screw hole) at the cis and the trans 
cortex.  
Inflammation was characterized by such cellular components as polymorphonuclear 
cells, eosinophils, lymphocytes, plasma cells, macrophages, giant cells, necrosis and 
osteolysis. 
Tissue response was described by remodeling reaction including neovascularization, 
fibrous capsule formation/fibrosis and fatty infiltration (at the cis and trans cortex area 
only). 
Due to the greater importance of inflammatory cell infiltrates and necrosis, these 
parameters were multiplied by a factor two to provide a weighted value as compared to 
tissue remodeling parameters, which describe more a secondary effect and healing 
response. The values were summarized, and then an average score for Test group and 
Control group calculated.  
The average score for the control treatment was subtracted from the Test group average 
to determine a comparative reactivity grade based on following scale: 
- minimal or no reaction (0.0 to 2,9) 
- slight reaction (3.0 to 8,9) 
- moderate reaction (9.0 -15.0) 
- severe reaction ≥15.1 
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Figure 2.23: Scoring scheme for Biocompatibility containing Inflammation, tissue response and additional 
observations. 
 Assessment of bone activity, tissue character and healing response in the gap 
area 
Bone activity parameters (bone resorption and formation), tissue character (endochondral 
ossification, maturity of callus) and healing response (defect unity) were evaluated using 
ground and thin sections in three different areas:  
• fracture ends and defect at trans-cortex  
• fracture ends and defect at cis-cortex  
• endosteal defect area. 
Scoring scheme is shown in Table 2.8. 
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Table 2.8: Scoring scheme for bone activity parameters, tissue character and healing response evaluated using 
ground and thin sections 
 
Figure 2.24: Thin section evaluation including biocompatibility assessment, bone activity parameter, tissue 
character and healing response. 
 Statistical Analysis  
Descriptive statistics were computed for the TI, CI and NCI groups in both the 3mm gap 
model and the 17mm graft model. Statistical analysis of data was performed to compare 
TI versus CI in both the 3mm gap model and the 17mm graft model using unpaired two-
tailed T-tests. Differences were considered statistically significant when the p-value was 
below 0.05. Statistical analyses and plots were performed with the SPSS software 
(version 23).  
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 3 mm Gap Model 
 Excluded Animals 
12/14 sheep completed the study as planned. Two animals (86.01, 86.02) had to be 
excluded and were replaced by reserve animals (86.28, 86.29).  
 
Animal 86.01 (TI) had to be excluded from the group analysis due to implant failure of 
the internal fixation. A complete collapse of the fracture gap laterally at the trans cortex 
was already detected 3 weeks post-surgery during radiographic examination. The two 
most distal screws (hole 11 and 12) were broken and the screw in hole 9 (closest to the 
distal end of the defect) was displaced and bent. The sheep showed a very nervous and 
uncooperative behavior, which was likely the primary cause of the fixation failure.  
 
 
Figure 3.1: Animal 86.01: anteroposterior projections of the left tibia taken 3- and 5-weeks post-surgery. 
Collapse of fracture gap due to implant failure (breakage of screw 12, indicated by the white arrow) and 
dislocation of screw 9 are visible already after 3 weeks, proceeding with breakage of screw 11 at the 5-week 
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In animal 86.02 (TI) the macroscopic evaluation at sacrifice revealed a moderately 
detached transducer cap at the proximal Marvel screw with fibrous tissue between cap 
and screw head. As it was not detected with radiographic follow up, the exact time point 
of cap detachment could not be determined. Therefore, the PEMF treatment may not have 
been systematically administered throughout the in-life phase. This observation 
prompted the decision to exclude this animal. 
 Anesthesia, surgery and post-operative recovery period 
As part of pre- surgical preparations, 2 to 3 days prior to surgery blood samples for 
hematology and chemistry examinations were taken and carefully examined. Any 
parameters suggesting possible infections (e.g. elevated white blood cell count), muscle 
disorders (elevated creatine kinase level), metabolic problems (kidney values: creatinine, 
blood urea; electrolyte levels: sodium, potassium, chloride, bicarbonate) or anemia (e.g. 
low red blood cell count) were taken into particular consideration. Only healthy animals 
were enrolled in the study.  
In total, 12 animals included in the group analysis (86.03-12, 86.28-29) underwent 
surgery with a 3 mm gap. The overall anesthesia time was between 123-334 min (Ø 
200min) and 223 minutes for the TI compared to 187 minutes for the CI. This parameter 
was not expected to influence the outcome of the study. The surgical procedure itself 
lasted between 61-125 min (Ø 92 min). 
In all 12 animals, the tibia osteotomies including internal fixation, as well as the 
placement of the Marvel screws could be performed without any complications. This was 
possible thanks to the advanced equipment, specially designed screw and cutting guides 
and experienced surgeons.  
For each sheep, the number of the used Universal Transducer SI-ES as well as the 
measured resistance (Ohm) was noted. The resistance values were within the functional 
range for both TI (between 90-102 Ohm) and CI (between 90-93 Ohm). The detailed 
measurements for each sheep are attached in Appendix 1. 
In 8/12 animals, no complications occurred during Marvel technology placement and 
recovery from anesthesia. The Universal Transducer SI-ES could be easily 
subcutaneously placed at the distal part of the tibia and caps tapped onto the screw heads 
using a hammer. Nevertheless, in 3/12 animals, the Universal Transducer SI-ES had to 
be replaced during or immediately after surgery. In one animal (86.03, TI), it was 
replaced because a too high resistance value (140 Ohm) was measured. In a second sheep 
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(86.09, TI), the cap could not be fixed at the screw head and therefore the transducer was 
immediately replaced during surgery. In a third sheep (86.10, TI), the postoperative 
radiograph revealed a detached cap at the distal screw. This sheep underwent a second 
surgery during the same anesthesia and the cap was fixed at the screw head again. Due 
to this second surgical intervention, the anesthesia time of this sheep was prolonged to 
334 min. Neither complications during anesthesia nor postoperative complications 
occurred. No further cap loosening occurred in these replaced or reattached caps. Due to 
the complications related to the cap attachment at the hexagonal screw head, the caps 
were re-worked, so that in the last two sheep of the 3mm model (86.28, 86.29), 
transducers with re-worked caps were implanted. No further complication concerning 
cap loosening was observed with these re-worked caps. 
In 1/12 sheep (86.07), an anesthesia complication occurred. This animal developed a 
respiratory arrest immediately after extubation. Due to difficult reintubation with various 
intubation attempts an injury with strong bleeding and massive swelling of the larynx 
occurred. In addition, a pulmonary edema was diagnosed, which was immediately treated 
with furosemide twice (first dose: 4mg/kg BW, second dose after 10 minutes: 2 mg/kg 
BW). Phenylephrine was applied onto the larynx and into the nose to subdue the swelling. 
The sheep was mechanically ventilated and stabilized over half an hour. After the second 
extubation, oxygen was applied via an intranasal catheter. After one hour, the sheep 
recovered and was transported to the stable, no further complications occurred during the 
recovery period of this sheep. 
 Detached transducer caps after surgery and re-design 
In total 9/24 transducer caps became detached, either already during surgery (N=2), or 
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Group Animal  Proximal cap detached Distal cap detached 
excluded 86.02 
slightly detached, fibrous tissue between 
cap and screw head, detected at sacrifice, 
not visible during radiographic 
examination 
- 
CI 86.04 - 
detached but still in place, 
radiologically detected at 4 weeks 
post OP 
CI 86.07 radiologically detected at 7w post OP 
radiologically detected at 4w post 
OP 
CI 86.08 radiologically detected at 5w post OP 
radiologically detected at 3w post 
OP 
CI 86.09 
transducer replaced during surgery 
because cap did not hold  
- 
TI 86.10 - 
postoperative radiograph revealed 
detachment, therefore 2. Surgery 
during the same anesthesia  
TI 86.12 
radiologically detected at 5w post OP, 2. 




5 in total (3 in CI, 2 in TI) 4 in total (3 in CI, 1 in TI) 
Table 3.1: Detached caps in the 3 mm gap model.  
 
In two TI animals (86.03, 86.10), the caps detached already during surgery and were 
immediately reattached still under the same general anesthesia. 5 caps of 3 CI animals 
(86.04, 86.07, 86.08) became detached between 3-7 weeks post-surgery. These 
detachments were all detected during the weekly radiographic examination. No 
reattachment was performed because they belonged to the non-treated CI group. 
In one animal of the TI group (86.12), cap loosening at the proximal screw was observed  
5 weeks after surgery during the weekly radiographic examination. This sheep underwent 
a second surgery and the cap successfully was reattached. Therefore, a 5 cm long incision 
was made cranially of the plate in the area of the proximal Marvel screw. Antibiotics and 
analgesics were given intravenously for three days. No further complications evolved 
from this event. The re-worked caps were implanted in animals 86.28, 86.29 and no 




 In-life clinical observations 
None of the 12 animals included in the group analysis revealed serious or persistent 
clinical abnormalities influencing the overall outcome of the study.  
The casts were successfully changed during every radiographic examination and were 
carried until the sacrifice.  
Four animals (TI: 86.11, 86.28, CI: 86.04, 86.07) developed pressure sores, mostly at the 
knee region. Special care was taken that the cast edges were always sufficiently padded 
and that the cast ended above the patella. Pressure sores were treated with betadine 
solution and honey cream and healed well within a few weeks. Three animals (TI: 86.03, 
CI: 86.05, 86.09) lied down more than usual without any further clinical signs.  
All animals tolerated both the casts and coils and therapy could be applied without 
complications. 
 Macroscopic findings at sacrifice 
In all 12 animals, the sacrifice procedure after 9 weeks was performed according to 
routine. A careful macroscopic examination was successfully conducted. All samples, 
including lymph nodes and both tibiae were harvested as planned.  
Overall, the anatomical dissection performed right after sacrifice showed that in both TI 
and CI groups, the tissue adjacent to the implants did not show any alteration of the 
normal structure. No hematoma, edema, encapsulation or other additional gross findings 
were recorded. The universal transducer and its cables stayed in place. No encapsulation 
or granuloma were found around the implanted Marvel technology (universal transducer, 
cables, caps). The status of the detached caps detected radiographically during the in-life 
period (Table 3.1) was confirmed macroscopically at sacrifice. No further cap 
detachment was detected. 
Resistance of the transducer was successfully measured in order to confirm its connection 
to the caps. In TI, the resistance values ranged from 88 to 300 Ohm, whereas in CI, from 
86 to 110 Ohm or were not functional. Meticulous exploration of the gap area and 
verification of fragment stability showed a macroscopically stable callus in 6/6 TI and 
5/6 CI tibiae. In 1/6 CI sample (86.07), the fracture ends were movable and the gap 
unstable. 
In addition, no macroscopic abnormalities were found in all harvested lymph nodes. 
98/108 locking head screws (TI=49, CI=49) were found locked and correctly placed in 
the plate. 10/108 screws were found between slightly and severely displaced in 1/6 
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animals of the TI group (86.03: N=2) and in 4/6 animals of the CI group (84.04: N=3, 
86.05: N=1, 86.06: N=1, 86.08: N=3). Out of these, two screws of two CI animals were 
broken at the neck (86.04, 86.05). No macroscopic abnormalities seemed to be directly 
related to these broken screws. Nevertheless, in animal 86.04, the body of the broken 
screw could not be removed and remained in the bone, causing some artefacts for µ-CT 
scanning. 
Metallosis at the screw head - plate junction was found in all sheep of both groups (TI=6, 
CI=6) dominantly at the distal screw holes 9 - 12.  
All 24 Marvel screws were firmly integrated in the bone, no macroscopic loosening was 
observed and no metallosis was found.  
 Micro-CT morphometry and structural analyses 
The global morphometric analysis using the “slice by slice” tissue segmentation was 
performed successfully and accurately depicted callus and cortical bone. Also the highly 
mineralized callus could be successfully distinguished from the old bone. Looking at the 
results of the global morphometry, box plots representing all 12 animals (6 TI and 6 CI) 
are shown in Figure 3.2. 
Although differences in callus volume and mature callus volume were not detected 
between CI and TI, a clear tendency for higher callus density in TI was observed 
(p=0.053), with a mean difference of 88.44 mg HA/cm3.  
 
Figure 3.2: Callus volume in cm3, mature callus volume in cm3, callus mineral density in mg HA/cm3 comparing 








































































































































































Biomechanical testing gave a comprehensive assessment of the fracture healing 
response. All results are reported as mean ± SD. 
The gauge length was 148 ± 6 mm for non-operated tibiae and 146 ± 14 mm for operated 
tibiae. Non-operated tibiae from the 3 mm gap model (12 in total) exhibited an overall 
torsional stiffness of 6.77 ± 1.76 Nm/deg. The non-operated tibiae in the CI group had a 
torsional stiffness of 6.04 ± 1.51 Nm/deg while the non-operated tibiae in the TI group 
had a torsional stiffness of 7.51 ± 1.81 Nm/deg. This difference was not statistically 
significant (p=0.158).  
The operated tibiae in the CI group had a torsional stiffness of 3.25 ± 2.41 Nm/deg while 
the operated tibiae in the TI group had a torsional stiffness of 6.13 ± 2.73 Nm/deg. This 
difference was also not statistically significant (p=0.081), likely due to the high 
variability between samples (74% and 44% relative standard deviation in CI and TI 
respectively). Stiffness values for individual animals are shown in Appendix 7: 
Biomechanics. 
 
Figure 3.3: Torsional stiffness in Nm/deg of operated and non-operated tibiae and percent (%) torsional 
stiffness of operated tibiae compared to contralateral non-operated tibiae in CI and TI (n = 6). 
Normalizing the operated tibia stiffness to the contralateral non-operated tibia stiffness, 
the TI group tibiae reached 78 ± 26 % of the contralateral non-operated tibiae stiffness. 
The CI group tibiae reached 57 ± 40 % of the contralateral non-operated tibiae stiffness. 
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The difference between CI and TI was also not statistically significant (p = 0.322). 
Normalized stiffness values for individual animals are shown in Appendix 7: 
Biomechanics. The operated tibia from sheep 86.07 (CI) had a very low torsional 
stiffness (0.07 Nm), indicating a delayed union.  
 Radiographic evaluation  
 Semiquantitative Scoring of radiographs  
It was possible to evaluate all radiographs of the 3mm gap model. The analysis was 
performed by two independent, board certified reviewers (Prof. Brigitte von Rechenberg 
and Prof. Mark Flückiger). Radiographs were randomly presented unknown for group 
and time point. Overall, the congruency of scores was very high and of those differing 
the mean value between both scores were taken.  
Radiographs were taken of all animals immediately after surgery and as proposed when 
changes of casts were performed at 3, 4, 5, 6, 7 and 8 weeks. Radiographs at 9 weeks 
were taken after sacrifice but still with the same conditions as if they would have been 
done in-life. Identical settings were used (50 kV, 2.0 mAs).  
Performing radiographs at 3 angled projections (0°, 265° and 275°) was highly reliable 
and allowed good assessment of each sides of the callus. The anteroposterior (0°) 
projection was used not only for the detailed gap area evaluation but also for the healing 
at the cis and trans cortices as the position of the plate, screws and the Marvel technology 
components allowed for a clear undisturbed view of the defect.  
The 265° and 275° angled projections were used for the evaluation of the healing 
progression on the caudal and cranial tibia cortices respectively. Additionally, these 
projections made it possible to detect any caps loosening or detachments. 
Callus formation at the cranial cortex could be visualized in radiographs taken at the 275° 
angle whereas new bone formation at the caudal cortex was clearly visible in radiographs 
taken at the 265° angle.  
Overall, callus formation was enhanced in the TI compared to the CI group. Callus 
formation was visible as early as 3 weeks in both groups, although mainly at the trans 
cortex stemming from the periosteum. In the TI group, the callus formation was more 
advanced, smaller in size and focused at the gap compared to the CI group, where three 
animals (86.04, 86.06 and 86.08) showed callus formation at the gap resembling slightly 
an irritation callus. In all three of these animals, a slight collapse at the trans-cortex was 
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noticed. In the TI group, all animals showed callus formation at the gap and periosteum. 
Differences of callus formation between groups started at 4 weeks and were more 
pronounced at 5 weeks. In 5/6 sheep (86.10, 86.11, 86.12, 86.28 and 86.29), a bridging 
callus was noticed at this time point in the TI group, whereas in CI only in 3/6 animals 
(86.04, 86.06, 86.08). At 6, 7 and 8 weeks, differences were even more pronounced. At 
the time of sacrifice, 5/6 sheep of TI showed a bridging callus (sheep 86.10, 86.11, 86.12, 
86.28 and 86.29) compared to 3/6 in CI (sheep 86.04, 86.06, 86.08). The quality of the 
callus (smoothness, size and opacity) was superior in the TI group. 
Individual scores corroborated these results. Differences over time starting at 5 weeks, 
although not statistically significant, showed a clear tendency for higher values of TI. 
The mean total score (overall callus) was higher in the TI group throughout the entire 
time period from 3 to 9 weeks. The total score consisted of the addition of all individual 
semiquantitative scores. It included the scores of cortical callus formation, Rust score, 
cis and trans cortex at 0° angle, cranial at 275° angle and caudal score at 265° angle and 
callus opacity.  
 
Figure 3.4: Mean ± SD total radiographic score (0 – 30) plotted for TI and CI (n=6) at 3, 4, 5, 6, 7, 8 and 9 weeks 
post-operatively. The means are also listed in the table. 
 
Cortical callus formation demonstrated similar results as the total scores. It was highest 
between 5 and 7 weeks. After 7 weeks differences became smaller due to the fact that in 
the TI group the callus had already bridged. 
3 weeks 4 weeks 5 weeks 6 weeks 7 weeks 8 weeks 9 weeks
CI 7.3 9.9 12.1 12.1 13.3 13.8 14.6
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The RUST Score was also higher in the TI group mainly between 5 and 9 weeks. At  
4 weeks, scores of the TI group were even slightly lower compared to the CI group. 
 
 
Figure 3.5: Mean ± SD of cortical callus formation score (0 – 4) and RUST score (1 – 4) for TI and CI (n=6) at 
3, 4, 5, 6, 7, 8 and 9 weeks post-operatively. The means are also listed in the tables. 
 
The cis cortex showed also higher scores starting at 5 and extending to 9 weeks. At earlier 
time points (3 and 4 weeks) almost no differences were noticed. The mean highest score 
was at 9 weeks with 2.7 out of a maximum of 4.  
The trans cortex showed higher scores throughout the entire period from 3 to 9 weeks. 




Figure 3.6: Mean ± SD of cis cortex score (0 – 4) and trans cortex score (0 – 4) for TI and CI (n=6) at 3, 4, 5, 6, 




The cranial cortex evaluation focus was on healing at the cis cortex. Scores over time in 
this area were almost identical as in the trans cortex, except in the early time points of 3 
and 4 weeks, where scores were slightly lower.  
The caudal cortical gap revealed scores of the trans cortex. Similar to the RUST Score, 
the TI group showed a slightly lower score than the CI group, but at all other time points 
TI scores were higher. 
 
 
Figure 3.7: Mean ± SD of cranial cortical gap score (1 – 4) and caudal cortical gap score (1 – 4) for TI and CI 
(n=6) at 3, 4, 5, 6, 7, 8 and 9 weeks post-operatively. The means are also listed in the tables. 
 
Callus opacity was higher in the TI group compared to the CI throughout the entire 
period. Only at 3 weeks, scores were equal in both groups. However, it has to be noticed 
that scores were always below 2 indicating that opacity was always less than 50% of the 
original cortical bone.  
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Figure 3.8: Mean ± SD of callus opacity score (1 – 3) for TI and CI (n=6) at 3, 4, 5, 6, 7, 8 and 9 weeks post-
operatively. The means are also listed in the table. 
 
Screw tip callus formation described the periosteal reaction at the tip of the Marvel 
screws that always penetrated the trans cortex until the first thread. Although it did not 
contribute any stability to the overall callus, it was expected to indicate a reaction of the 
osteogenic periosteum through the pulsed electromagnetic stimulation. Callus formation 
at both Marvel screws was observed in all TI sheep from week 4 onwards, whereas this 
was only observed in 4/6 CI sheep from 4 weeks onwards and 1/5 CI sheep from 7 weeks 
onwards. One CI sheep only developed callus formation at one Marvel screw tips. Since 
this valuable did not contribute to the stability of the gap healing it was not included in 
the summary of the total score. 
 
Cortex blurring described the stage of bone resorption and new bone formation, which 
radiographically is indicated through blurring of the fragment edges. Since cortex 
blurring does not contribute to the overall stability of gap healing, the parameter was not 
included in the total score calculations. However, more cortex blurring is a sign of higher 
callus maturity. Differences between the groups were obvious between 5 and 9 weeks, 
where 5/6 TI sheep clearly showed cortex blurring already at 5 weeks while 5/6 CI sheep 





Twelve toluidine blue stained histological ground sections were histomorphometrically 
evaluated with success. Microradiographs of the ground sections were used to 
corroborate the structure of calcified tissue in the toluidine stained samples. 
The evaluation was performed using total section and sectoral analysis. For each sample, 
percentages of old bone, new bone, as well as non-bone structures (non-bone containing 
tissue) were successfully measured for the total section. Sectoral evaluation made it 
possible to distinguish new bone formation at the endosteal, cis and trans area in all 
samples. 
Overall, histomorphometrical measurements revealed comparable and good healing of 
the gap area for both TI and CI.  
 Total section evaluation 
Overall, no significant differences were found between TI and CI for any of the values 
of the total section analysis. Nevertheless, slightly higher values were found for old and 
new bone in TI, while values for non-bone tissue were slightly lower in TI than CI. 
Mean results and their standard deviations for histomorphometrical evaluation of the total 
section are shown in Figure 3.9 and Table 3.2. 
 
Figure 3.9: Histomorphometric measurements 9 weeks post-surgery of % old bone, % new bone, and % non-
bone structures for TI (n=6) and CI (n=6). Results represent the percentage of the total area measured. 
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Table 3.2: Histomorphometric measurement means 9 weeks post-surgery of % old bone, % new bone, and % 
non-bone structures for TI (n=6) and CI (n=6). Results represent the percentage of the total area measured. 
 Sectoral evaluation 
Overall, no statistically significant differences were found between TI and CI for any of 
the values of the sectoral analysis. Slightly higher values were found for callus formation 
at the cis- and at the trans cortex in TI and higher values endosteally in CI. 
Mean results and their standard deviations for the sectoral histomorphometrical 
evaluation are shown in Figure 3.10 and Table 3.3. 
 
Figure 3.10: Sectoral histomorphometric measurements 9 weeks post-surgery of % endosteal callus, % trans 








CI 27.26 23.01 49.73



































Table 3.3: Sectoral histomorphometric measurement means 9 weeks post-surgery of % endosteal callus, % 
trans callus and % cis callus for TI (n=6) and CI (n=6). Results represent percentage of the total area 
measured). 
 Fluorescence  
It was possible to evaluate 12 unstained histological fluorescence sections of two groups, 
TI (N=6) and CI (N=6). Fluorescence markers were injected at 3 weeks (calcein green), 
6 weeks (xylenol orange), and 9 weeks post-surgery (oxytetracycline, 48 hours prior to 
sacrifice).  
Fluorescence dyes were well visible in all specimens. Calcium deposition at the various 
time points could easily be followed with the different colors in all samples but one 
(86.07). In this sample calcein green was hardly visible at 3-week time point. At 6- and 
9-weeks slight deposition mainly in the bone marrow cavity was seen (delayed union, 
Figure 3.11). 
At 3 weeks calcein green deposition was only detected in small amounts, mostly at the 
transcortical periosteal callus in both TI and CI (Figure 3.12 and Figure 3.13).  
At 6 weeks xylenol orange was visible in moderate quantities in both TI and CI. It could 
also be detected within the bone marrow and the gap at both cortices. Slightly pronounced 
visibility was recorded for TI versus CI at both cortices (Figure 3.12 and Figure 3.13).  
At 9 weeks oxytetracycline indicated good calcium deposition and therefore an ongoing 
remodeling process in the cis and trans cortex of the TI group and to a lesser degree 
within the bone marrow. In the CI group, this relationship was inverted (more deposition 
within the bone marrow than at the cortices)(Figure 3.12 and Figure 3.13). 
 
 






CI 15.00 34.54 50.46
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Calcein green at 3 weeks Xylenol orange at 6 weeks Oxytetracycline at 9 weeks 
Figure 3.11: Fluorescence images of 86.07 CI, at 3 weeks only hardly visible calcium deposition, at 6 and 
9 weeks slight deposition, but mainly in the bone marrow cavity and not in the gap area (delayed union)  
 
Calcein green at 3 weeks Xylenol orange at 6 weeks Oxytetracycline at 9 weeks 
Figure 3.12: Representative fluorescence images for TI (86.11), only slight calcium deposition at 3 weeks, 
pronounced deposition especially at the fracture ends at 6 and 9 weeks 
 
Calcein green at 3 weeks Xylenol orange at 6 weeks Oxytetracycline at 9 weeks 
Figure 3.13: Representative fluorescence images for CI (86.09), only slight calcium deposition at 3 weeks, 
more pronounced at 6 and 9 weeks mostly in the bone marrow cavity 
 Histological evaluation 
Assessment of biocompatibility parameters (inflammation and tissue response) and 
additional observations (traumatic necrosis and foreign debris) of TI and CI at the Marvel 
screws surrounding tissue of each tibia sample were performed without any problems. 
Bone activity (resorption and formation), tissue character (cartilage formation, callus 
maturity) and healing response (defect unity) were scored at the facture ends of cis and 
trans cortices as well as in the whole gap area. 
A total of 36 Hematoxylin-Eosin (N=12), toluidine blue (N=12) and von Kossa stained 
(N=12) histological sections of two groups (TI:6 and CI:6) were evaluated according to 




 Semiquantitative analysis of local tissue effects 
Neither test nor control item demonstrated any abnormal tissue reactions. In both groups, 
a physiological number of immune cells within the bone marrow cavity surrounding the 
Marvel screws was observed. Individual results are listed in Table 3.4. 
Overall, no polymorphonuclear cells, eosinophils, lymphocytes, plasma cells, necrosis, 
osteolysis, fatty infiltrates or foreign debris were noted in the area of the Marvel screws 
in any of the TI or CI samples.  
Mild to moderate fibrosis in combination with neovascularization was found in 1/6 
samples of TI (mild in 86.11) and in 3/6 samples of the CI (mild in 86.08, 86.09 and 
moderate in 86.07).  
In 86.07, this was accompanied by a moderate number of macrophages and giant cells.
 
Table 3.4: Results of biocompatibility evaluation at the Marvel screws and surrounding tissue of each tibia 
sample (light grey labelled animals TI group) for the 3 mm gap model. 
 
Evaluation zone:  Marvel screws and surrounding
Test group: PEMF-treated
Control group: non-treated
86.03 86.10 86.11 86.12 86.28 86.29 86.04 86.05 86.06 86.07 86.08 86.09
1. Inflammation
Polymorphonuclear 0 0 0 0 0 0 0 0 0 0 0 0
Eosinophils 0 0 0 0 0 0 0 0 0 0 0 0
Lymphocytes 0 0 0 0 0 0 0 0 0 0 0 0
Plasma cells 0 0 0 0 0 0 0 0 0 0 0 0
Macrophages 0 0 0 0 0 0 0 0 0 2 0 0
Giant cells 0 0 0 0 0 0 0 0 0 2 0 0
Necrosis/ osteolysis 0 0 0 0 0 0 0 0 0 0 0 0
SUB-TOTAL 0 0 0 0 0 0 0 0 0 4 0 0
SUB-TOTAL (x2) 0 0 0 0 0 0 0 0 0 8 0 0
2. Tissue response
Neovascularisation 0 0 1 0 0 0 0 0 0 2 1 1
Fibrosis/fibrous membrane 0 0 1 0 0 0 0 0 0 2 1 1
Fatty infiltrate 0 0 0 0 0 0 0 0 0 0 0 0
F.2 SUB-TOTAL 0 0 2 0 0 0 0 0 0 4 2 2
TOTAL (1.+2.) 0 0 2 0 0 0 0 0 0 12 2 2
GROUP TOTAL
Average (Ø)
Ø TI - Ø CI *
Traumatic necrosis 0 0 0 0 0 0 0 0 0 0 0 0
Foreign debris 0 0 0 0 0 0 0 0 0 0 0 0
Conclusion: Under the conditions of this study, the Test group was considered to demonstrate the following:
 X      minimal or no reaction (0.0 up to 2.9);
         slight reaction (3.0 upt to 8.9);
 _      moderate reaction (9.0 upt to 15.0);
         severe reaction (>15.1)


















Test group Control group
Animal ID
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 Semiquantitative analysis of bone activity, tissue character and healing 
response in the gap area 
For both TI and CI groups, bone activity parameters showed high scores for bone 
formation (Score 3-4: between 51-100% new bone formation) at the fracture ends and in 
the gap area. Slightly higher bone activity scores were achieved by the TI. For all TI 
samples and 5/6 CI samples, bone resorption was only observed within a normal range 
(score 0-1, 0-25%), typical for a bone remodeling process. One control item animal 
(86.07) showed moderately elevated scores for bone resorption with a score value of 2 
for cis cortex (resorption reaching 26-50%) and 3 for the trans cortex (51-75%).  
Tissue character was described based on the maturity of the callus and presence of 
endochondral ossification within the fracture gap and at the fracture ends. The mean total 
score for callus maturity was higher in TI (3.50) comparing to CI (2.72). In the TI, newly 
formed bone at the fracture ends (both cis and trans) was already highly organized and 
integrated. This was characterized by dense and regularly oriented structure in the 
longitudinal axis. Furthermore, in comparison to CI a more pronounced degree of 
vascularization and a thicker osteoid seam with highly activated osteoblasts (Figure 3.14 
M) was evident. Endochondral ossification was higher in CI (score=0.89), indicating a 
less advanced healing process compared to TI (score=0.22). The overall healing response 
was characterized by a defect unity score, which showed higher values for gap closure in 
the TI with a mean total score of 3.56 compared to CI with 2.78. 
Individual scoring results for semiquantitative analysis of bone activity, tissue character 
and healing response in the gap area of TI and CI are illustrated in Table 3.5. 




Table 3.5: Results for semiquantitative analysis of bone activity, tissue character and healing response in the 
gap area (range: 0-4) for TI and CI. 
Cis defect trans cis defect trans cis defect trans cis defect trans cis defect trans
86.03 0 1 1 3 3 2 1 0 0 3 2 1 2 3 1
86.10 0 0 0 4 4 4 0 0 0 4 4 4 4 4 4
86.11 0 0 0 4 4 4 0 0 0 4 4 4 4 4 4
86.12 0 1 1 4 3 3 1 1 1 3 3 3 4 4 3
86.28 0 1 0 4 4 3 0 0 0 4 4 4 4 4 3
86.29 0 0 0 4 4 4 0 0 0 4 4 4 4 4 4
Mean 0 0.50 0.33 3.83 3.67 3.33 0.33 0.17 0.17 3.67 3.50 3.33 3.67 3.83 3.17
Mean total 
gap
86.04 0 0 0 4 4 4 1 0 1 3 4 4 3 4 4
86.05 0 0 1 4 4 3 1 2 2 4 3 2 4 4 1
86.06 0 0 0 4 4 4 0 0 0 4 4 4 4 4 4
86.07 2 0 3 1 3 0 0 2 0 0 3 0 1 2 1
86.08 0 0 1 4 4 2 1 1 0 4 4 2 4 4 2
86.09 1 0 1 2 3 0 1 4 0 2 2 0 1 3 0



















0.50 3 0.89 2.72 2.78
0.28 3.61 0.22 3.50
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A: Animal 86.11, TI, overview gap, well organized 
callus at both cortices, no callus around the marvel 
screws in the bone marrow cavity, toluidine blue, 
mag. 1x7.11 
 
B: Animal 86.08, CI, overview gap, good bone 
formation at the cis cortex, a lot of callus in the 
bone marrow cavity, gap not completely healed at 
the trans cortex, a lot of periosteal callus formation 









C: Animal 86.11, TI, gap area at cis cortex, new 
bone highly organized, characterized by dense and 
regularly oriented structure according to the 
longitudinal axis at the fracture ends (arrows), 
toluidine blue, mag. 1x15.5 
 
D: Animal 86.08, CI, gap area at cis cortex, new 
bone formation at the fracture ends (still 
pronounced and oriented to the transverse axis, 
black arrows), visible isles of endochondral 
ossification and mesenchymal tissue, callus 
formation within bone marrow cavity, toluidine 




E: Animal 86.11, TI, higher magnification, smooth 
transition zone fracture end to gap area at cis cortex 
(black circle), new bone highly organized, 
characterized by dense and regularly oriented 
structure, toluidine blue, mag. 1x45 
 
F: Animal 86.08, CI, higher magnification, sharp 
transition zone fracture end to gap area at cis 
cortex (black circle), new bone formation, fracture 
ends still pronounced, callus within gap 
disorganized, visible isles of mesenchymal tissue, 
toluidine blue, mag. 1x45 
 
G: Animal 86.11, TI, gap area at trans cortex, gap 
completely remodeled and united (black arrows), 
periosteal callus formation, smooth transition zone, 
new bone highly organized, characterized by dense 
and regularly oriented structure at the fracture 
ends, toluidine blue, mag. 1x15.5 
 
H: Animal 86.08, CI, gap area at trans cortex, gap 
not completely united (black arrow), large 
periosteal callus formation, new bone formation at 
the fracture ends (still pronounced), visible isles of 
endochondral ossification and mesenchymal 
tissue, callus within gap disorganized, toluidine 
blue, mag. 1x15.5 
 
I: Animal 86.11, TI, higher magnification, smooth 
transition zone between fracture end to gap area at 
trans cortex (black circle), new bone highly 
organized, characterized by dense and regularly 
oriented structure, toluidine blue, mag. 1x45 
 
J: Animal 86.09, CI, higher magnification, sharp 
transition zone between fracture end to gap area at 
trans cortex (black circle), new bone formation, 
fracture ends irregular after resorption, less bone 
formation, abundant mesenchymal tissue, toluidine 
blue, mag. 1x45 
Results 
   81 
 
K: Animal 86.11, TI, overview image, smooth 
transition zone between fracture end to gap area at 
cis cortex, new bone highly organized, characterized 
by dense and regularly oriented structure, thick 
osteoid seam, activated osteoblasts, von Kossa 12.5 
 
L: Animal 86.08, CI, overview image, transition 
zone between fracture end to gap area at cis 
cortex, new bone with bigger intertrabecular 
spaces than in TI, von Kossa 12.5 
 
M: Animal 86.11, TI, detail image, thick osteoid 
seam, highly activated osteoblasts, von Kossa 100x 
 
N: Animal 86.08, CI, transition zone between 
fracture end to gap area at cis cortex, ativated 
osteoblast, thinner osteoid seam than in TI, von 
Kossa 50x 
Figure 3.14 A-N: Representative images of histological thin sections for TI and CI. 
 
 17 mm Graft Model 
 Anesthesia, surgery and post-operative recovery period 
In total, 15 animals underwent surgery with a 17mm gap, which was either filled with 
autograft (12/15) or not filled (3/15 animals). The overall anesthesia time was between 
132-236 min (Ø 196 min) and no complications occurred. The surgical procedure lasted 
between 83-109 min (Ø 99 min).  
In 14/15 animals, the tibia osteotomies including internal fixation, as well as the 
placement of the Marvel screws could be performed without any complications. Only in 
one sheep of the TI (86.18), the osteotomy cuts were not completely parallel (about 1 
mm off) due to a problem with the cutting guide. Nevertheless, the alignment of proximal 
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and distal tibia was good, despite the misalignment of the cut. In all sheep (N=12) with 
autograft filling of the gap, the harvesting at the iliac crest could be performed without 
any complications. 
For each sheep, the number of the used Universal Transducer SI-ES as well as the 
measured resistance (Ohm) was noted. The resistance values were within the functional 
range for all TI (between 90-102 Ohm). In CI, the resistance ranged from 38 to 300 Ohm 
or some transducers were not working. The detailed measurements for each sheep are 
attached in Appendix 2. 
 
No complications occurred during the Marvel technology placement (no detached caps, 
no failures in resistance measurements for TI animals). The Universal Transducer SI-ES 
was easy to place subcutaneously at the distal part of the tibia and caps were easy to tap 
to the screw heads. All 15 animals were operated with the re-worked transducer caps, 
and therefore no detachment occurred. 
 In-life clinical observations 
None of the 15 animals included in the group analysis revealed serious or persistent 
clinical abnormalities influencing the overall outcome of the study.  
After a surgery was completed, each sheep received a full limb cast, which was changed 
every three weeks during radiographic follow-up examinations and successfully carried 
until the sacrifice day. Additional cast changes were performed in cases of cast breakage 
or a cast causing discomfort of an animal. All animals were successfully put in a specially 
designed suspension system for sheep, thanks to which shear forces put on the operated 
limb could be minimized. All animals accepted the casts without any issues and majority 
of them (13/15) tolerated the suspensions systems with no complications. One animal 
(86.13, CI) developed head and neck edema in the first night after surgery due to 
positional self-compression of the jugular veins in the suspension system. The animal 
was treated with furosemide, additional paracetamol & buprenorphine in standard 
dosages and fully recovered within 2 days and could stay in the suspension system 
without other complications. The other animal (86.25, NCI) showed repetitive edematous 
swelling of the left front limb caused by the suspension belt, therefore it needed to be 
taken out of suspension after 24 days post OP (4 days earlier than planned). The animal 
fully recovered within the next day.  
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In the 12 animals, which underwent autograft harvesting at the iliac crest, pain 
medication was adapted (additional paracetamol for 3-4 days) and consequently the 
animals did not seem more painful despite the more invasive surgery. 
6 weeks post-surgery, one animal (CI: 86.22) developed pressure sores at the udder, 
caused by irritation and pressure due to the cast. The animal received antibiotics 
(amoxycillin, 15 mg/kg BW, im) and analgesics (carprofen 4 mg/kg BW sc) for 8 days. 
After 10 days the animal did fully recover without further complications. Two animals 
(TI: 86.20, 86.21) lied down more than usual. 
All animals tolerated the coils and the therapy could be applied without complications. 
 Macroscopic findings at sacrifice 
In all 15 animals, the sacrifice procedure after 12 weeks could be performed without 
encountering any problems, according to routine. All samples, including lymph nodes 
and both tibiae could be harvested as planned.  
Overall, the anatomical dissection performed right after sacrifice showed that in both 
groups, TI and CI, the tissue adjacent to the implants did not show any alteration of the 
normal structure. No hematoma, edema, encapsulation, and/or other additional gross 
findings were recorded. The universal transducer and its cables stayed in place and did 
not interfere with the larger gap. No encapsulation or granuloma were found around the 
implanted Marvel technology (universal transducer, cables, caps). No cap detachment 
was detected in any animal from this model. 
Resistance of the transducer was measured in order to confirm its connection to the caps. 
In TI, the resistance values ranged from 0.136 to 91 Ohm, whereas in CI from 0.38 to 88 
Ohm or were not functional. Exploration of the gap area and verification of fragment 
stability showed a macroscopically stable callus in all TI and only 2/6 CI (86.14, 86.15) 
tibiae. In 5/6 CI samples the gap was unstable, while in 3/3 NCI samples the gap was 
highly unstable. The gaps of all three NCI samples were collapsed and the plates slightly 
(86.25, 86.27) and severely bent (86.26). 
 
In addition, no macroscopic abnormalities were found in all harvested lymph nodes. 
148/150 locking head screws were found locked and correctly placed in the plate. Only 
2/150 locking head screws of one TI animal were found slightly displaced, but firm. No 
broken screws were observed in all animals.  
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Metallosis at the screw head - plate junction was found in all sheep of all three groups 
(TI=6, CI=6, NCI=3) dominantly at the distal screw holes 9 – 12, but also at screw hole 
6 (TI=3/6, CI=4/6, NCI=3/3).  
All Marvel screws (N=30) were firmly integrated in the bone, no macroscopic loosening 
was observed. 
 Micro-CT morphometry and structural analyses 
The global morphometric analysis was successfully performed and gave a 
comprehensive assessment of new bone formation.  
Results of the global morphometry showed significantly higher callus volume (p=0.003, 
mean difference = 4.61 cm3) and mature callus volume (p=0.002, mean difference = 3.02 
cm3) in TI compared to CI. Even though the callus density difference was not statistically 
significant, there was a notable trend for a higher value in TI (p=0.055).  
 
Figure 3.15: Callus volume in cm3, mature callus volume in cm3, callus mineral density in mg HA/cm3 
comparing CI and TI (n = 6). 
 
 Biomechanics 
Biomechanical testing was successfully done in all samples. All results are reported as 
mean ± SD. 
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Non-operated tibiae (12 in total) exhibited an overall torsional stiffness of 7.96 ± 1.13 
Nm/deg. The non-operated tibiae in the CI group had a torsional stiffness of 7.45 ± 1.15 
Nm/deg while the non-operated tibiae in the TI group had a torsional stiffness of 8.46 ± 
0.93 Nm/deg. This difference was not statistically significant (p=0.127).  
The operated tibiae in the CI group had a torsional stiffness of 2.23 ± 2.19 Nm/deg (98% 
relative standard deviation) while the operated tibiae in the TI group had a torsional 
stiffness of 5.81 ± 2.38 Nm/deg (48% relative standard deviation). The difference 
between CI and TI was statistically significant (p=0.022). Stiffness values for individual 
animals are shown in Appendix 7: Biomechanics. 
 
 
Figure 3.16: Torsional stiffness in Nm/deg of operated and non-operated tibiae and percent (%) torsional 
stiffness of operated tibiae compared to contralateral non-operated tibiae in CI and TI (n = 6). 
Normalizing the operated tibia stiffness to the contralateral non-operated tibia stiffness, 
the TI group tibiae reached 67 ± 21 % of the contralateral non-operated tibiae stiffness. 
The CI group tibiae reached 30 ± 29 % of the contralateral non-operated tibiae stiffness. 
The difference between CI and TI was also statistically significant (p = 0.034). 
Normalized stiffness values for individual animals are shown in Appendix 7: 
Biomechanics. 
 




















































































































p = 0.022 p = 0.034
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 Radiographic evaluation 
It was possible to radiographically evaluate all 17mm graft model samples. This was 
done by the same two independent board-certified reviewers (Prof. Brigitte von 
Rechenberg and Prof. Mark Flückiger). The same scores were used as for the 3 mm gap 
group, although with a few modifications. In the TI and CI group gaps were filled with 
autograft material. Therefore, it was not always possible to clearly distinguish between 
newly formed periosteal callus and remaining, resp. remodeling autografts. For this 
reason, cortical callus formation was considered as score 2, when periosteal callus 
formation over the defect area and autografts were joined and could not be distinguished 
from each other. Also defect opacity was divided into the opacity of the callus within the 
defect and periosteal callus bridging the defect. All other variables remained the same as 
in the 3 mm gap.  
For the NCI group, without autografts filling the defect, considerably lower callus 
opacity was reached. Therefore, scores were different already in the early time points, 
making it difficult to compare NCI radiographic results with the other groups. 
Overall, all radiographs were of excellent quality and positioning, such that assessment 
of the defect area could be made without problems. In general, the positive results of 
electromagnetic stimulation could be confirmed as in the 3 mm gap. Note, that the time 
of sacrifice was longer for this 17mm gap with 12 weeks follow-up compared to the 3mm 
gap.  
None of the defects were completely radiographically healed at 12 weeks. Bridging of 
the defects with callus was nearly complete in 5/6 TI sheep and apparent only in 1/6 
sheep in the CI group. In addition, the overall defect area appeared less evenly filled with 
bone, with more focally distributed areas in the control group compared to the treated 
group. In the NCI group, none of the defects was filled with callus and all three plates 
were bent with a collapse of the trans cortex.  
 Semiquantitative scoring of radiographs 
The total score of the 17mm defect was highest for the TI group, followed by the CI and 
last by the NCI. Generally, new bone formation around the autografts and increased 
callus formation within the defect was noticed already at 3 weeks in the TI and at 6 weeks 
in the CI group. 
Results 
   87 
 
Figure 3.17: Mean ± SD total radiographic score (0 – 30) for TI (n=6), CI (n=6) and NCI (n=3) at 3, 6, 9 and 12 
weeks post-operatively. The means are also listed in the table. 
 
Cortical callus formation in the anteroposterior view (0° angle) was usually more 
pronounced at the transcortical area, but new bone formation was also noticed around the 
autografts laid underneath the cis cortex. Overall, callus bridging almost 80-90% of the 
gap was noticed at the trans cortex already at 6 weeks in 5/6 sheep of TI, whereas in the 
CI group this was only the case in 1/6 sheep. At 9 weeks, this was even more pronounced 
with an overall increase of bone formation within the defect in the TI group, although the 
cis-cortical area was still clearly less dense. In the CI group, only 1/6 animals showed a 
bridging callus whereas the others still showed no bridging callus at the trans cortex. 
Radiographs of 3 sheep in both groups at 10 weeks showed no major advancement. At 
12 weeks 2/6 sheep of the TI group showed complete bridging while the others had only 
a small gap remaining at the trans cortex. The cis cortex was still less dense compared to 
the trans cortex. In the CI group, only 1/6 sheep showed bridging of the trans cortex, 
whereas the cis cortex was less dense than the one of the TI group. 
The RUST Score confirmed this trend (see Figure 3.18). 
3 weeks 6 weeks 9 weeks 12 weeks
CI 7.5 14.1 15.4 15.1
TI 10.1 17.4 18.8 18.8






















Figure 3.18: Mean ± SD cortical callus formation score (0 – 4) and RUST score    (1 – 4)  for TI (n=6), CI (n=6) 
and NCI (n=3) at 3, 6, 9 and 12 weeks post-operatively. The means are also listed in the tables. 
 
The cis cortex at a 0° angle showed a higher score in the TI compared to the CI group, 
although full bridging with remodeling of the cortical bone was not achieved at 12 weeks. 
The trans cortex at a 0° angle also showed higher scores in the TI group. In the early time 
points, the NCI showed more callus formation compared to the CI group. However, this 
has to be interpreted with caution. The NCI group received no autografts. Therefore, the 
slightest periosteal reaction could be easily noticed, whereas the autografts may have 
obscured the view for new callus formation. Nevertheless, scores between the TI and CI 
group were more pronounced between 3 and 6 weeks and then became gradually less 
between 9 and 12 weeks. 
 
Figure 3.19: Mean ± SD cis cortex score (0 – 4) and trans cortex score (0 – 4)  for TI (n=6), CI (n=6) and NCI 
(n=3) at 3, 6, 9 and 12 weeks post-operatively. The means are also listed in the tables. 
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The cranial cortical gap (cis cortex) at an 275° angle demonstrated also higher scores for 
the TI versus the CI group. Differences increased over time starting at 6 weeks for the TI 
group. In the NCI group, the scores decreased after 9 weeks indicating bone resorption 
and rounding of the cortical bone fragments. 
The caudal cortical gap (trans cortex) at an 265° angle revealed higher scores for the TI 
group, although not quite as pronounced as in the cranial cortical gap. Especially at 12 
weeks, scores of both groups were quite close. Scores of the NCI group were much lower. 
 
 
Figure 3.20: Mean ± SD of cranial cortical gap score (0 – 4) and caudal cortical gap score (0 – 4)  for TI (n=6), 
CI (n=6) and NCI (n=3) at 3, 6, 9 and 12 weeks post-operatively. The means are also listed in the tables. 
Callus opacity of the bridging callus was similar for both groups in the first 9 weeks for 
both, the TI and the CI group. The opacity of the NCI group was clearly lower.  
Callus opacity within the defects was higher scored in the treated group. However, this 
result has to be interpreted with some caution, since the opacity of the defect was already 





Figure 3.21: Mean ± SD of callus opacity score (0 – 3) and defect opacity score    (0 – 3)  for TI (n=6), CI (n=6) 
and NCI (n=3) at 3, 6, 9 and 12 weeks post-operatively. The means are also listed in the tables. 
 
Screw tip callus was also seen on both Marvel screw tips in 5/6 TI sheep already at week 
3. This was not seen in most (5/6) CI sheep until week 12. In the NCI group, no sheep 
developed callus at both Marvel screw tips at any timepoint.  
Cortex blurring was clearly observed (score of 1) in 5/6 TI sheep versus 3/6 CI sheep at 
6 weeks and in all TI and CI sheep at 9 weeks and 12 weeks. Meanwhile, sheep 86.26 
and 86.27 from the NCI group showed slight cortex blurring at 12 weeks, with the cortex 
blurring appearing more clearly in 86.26 at 9 weeks. 
 Histomorphometry 
12 toluidine blue stained histological ground sections (6 TI and 6 CI) were successfully 
evaluated histomorphometrically. Microradiographs of the ground sections were used to 
corroborate the structure of calcified tissue in the toluidine stained samples. 
The evaluation was performed using total and sectoral analyses. Concerning total section 
analysis, for each sample, percentages of old bone, callus (consisting of new bone and 
autograft material in the gap), non-bone structures and cartilaginous tissue were 
successfully measured in all samples. Notably, as opposed to the 3 mm gap model, 12 
animals in the 17mm graft model received autografts. Both autograft and newly formed 
bone were indistinguishable (due to enhanced remodeling process) and were, therefore, 
in this analysis together considered as callus. For the sectoral evaluation, the callus (also 
including autograft remnants) in the endosteal, cis and trans area could be distinguished 
in all samples. 
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Overall, histomorphometrical measurements revealed comparable and good healing of 
the defect area for both, TI and CI, with the TI showing a more advanced healing. 
 Total section evaluation 
Overall, no significant differences were found between TI and CI for any of the values 
of the total section analysis.  
Results for histomorphometric evaluation of the total section are shown in Figure 3.22 
and Table 3.6. The percentages of old bone were similar in TI and CI. The trend showing 
a slightly higher percentage of cartilaginous tissue remnants and non-bone tissue in the 
CI indicated a more advanced healing process in the TI. The percentage of callus tissue, 
showed a tendency of higher values for TI compared to CI (mean difference = 6.9%, 
n=6).  
 
Figure 3.22: Histomorphometric measurements 12 weeks post-surgery of % old bone, % callus, % non-bone 
structures and % cartilaginous tissue for TI (n=6, marked orange) and CI (n=6, marked blue). Results represent 




























Table 3.6: Histomorphometric measurement means 12 weeks post-surgery of % old bone, % callus, % non-
bone structures and % cartilaginous tissue for TI  (n=6) and CI (n=6). Results represent the percentage of the 
total area measured. 
 Sectoral evaluation 
Overall, no significant differences were found between TI and CI for any of the values 
of the sectoral analysis.  
Results of sectoral histomorphometric evaluation are shown in Figure 3.23 and Table 
3.7. Nevertheless, slightly higher callus values were found at the cis-cortex (mean 
difference = 4.52%) and endosteal (mean difference = 5.85%) in CI, while TI showed 
higher values at the trans-cortex (mean difference = 10.38%). 
  
Figure 3.23: Sectoral histomorphometric measurements 12 weeks post-surgery of % endosteal callus, % trans 
callus and % cis callus for TI (n=6, marked orange) and CI (n=6, marked blue). Results represent percentage 










CI 17.27 31.38 47.40 3.95
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Table 3.7: Sectoral histomorphometric measurement means 12 weeks post-surgery of % endosteal callus, % 
trans callus and % cis callus for TI (n=6) and CI (n=6). Results represent percentage of the total area measured). 
 
 Fluorescence 
12 unstained histological fluorescence sections of all TI and CI sheep were successfully 
evaluated. Fluorescent markers were successfully injected in all animals of the 17 mm 
graft model at 3 weeks (calcein green), 6 weeks (xylenol orange), and 12 weeks post-
surgery (48 hours prior to sacrifice). Fluorescent dyes were well visible in all specimens. 
Calcium deposition at the various time points could be easily followed with the different 
colors in all samples.  
 
Overall, both TI and CI revealed similar calcium deposition, which was slightly more 
pronounced compared to 3mm gap due to autograft remodeling. TI manifested more 
calcification at the cortices whereas CI more so in the bone marrow. The most active 
fluorescent signal was present at the 6-week time point.  
 
At 3 weeks, calcein green deposition was only slightly visible in TI and CI mostly within 
the defect area due to the remodeling process of the implanted autograft material. In 
comparison to the 3 mm gap model, the calcium deposition was not concentrated at the 
transcortical periosteum. The transcortical periosteum was removed during surgery of 
the 17 mm graft model in order to create a non-union defect, when the defect would be 
left empty. The NCI group presented a very weak fluorescent signal as well. However, it 
was not accumulated inside the defect but dispersed within the endosteum. 
 
At 6 weeks, xylenol orange was visible in a very similar distribution as calcein green at 
3 weeks but was more enhanced within both groups. Intramedullary calcium deposition 
was almost the same in TI and CI. However, increased deposition at the fracture ends 
especially at the trans cortex was evident in 5/6 TI samples (see Figure 3.24 - Figure 
3.26). The fluorescent signal in the NCI was less pronounced compared to the groups 






CI 24.09 41.75 34.16





which received autografts, but was still higher at 6 weeks compared to 3 weeks. These 
samples showed some calcium deposition along the cortices at week 6, which was not 
apparent at week 3. A particularly active signal was visible at the cis cortex of sheep 
86.26, as this was the place where the LCP plate bent and where the gap collapsed.  
 
At 12 weeks, a lower oxytetracycline signal (compared to the xylenol signal at 6 weeks) 
was seen in the TI and the CI group, indicating a more advanced but still ongoing 
remodeling process. Notably, some cortical areas in the fracture gap did not exhibit any 
activity. These areas corresponded with the cartilaginous tissue found in the 
histomorphometric evaluation of thick sections (see Figure 3.26). Also, NCI exhibited 
an overall lower signal intensity then the other groups (see Figure 3.27). 
 
   
Calcein green at 3 weeks Xylenol orange at 6 weeks Oxytetracycline at 12 weeks 
Figure 3.24: Fluorescence images of 86.14 CI, at 3 weeks only hardly visible calcium deposition, at 6 and 9 
weeks slight deposition, but mainly in the bone marrow cavity and not in the gap area (delayed union). 
 
   
Calcein green at 3 weeks Xylenol orange at 6 weeks Oxytetracycline at 12 weeks 
Figure 3.25: Representative fluorescence images for TI (86.16), only slight calcium deposition at 3 weeks, 
pronounced deposition at 6 and 12 weeks in the whole defect area. 
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Calcein green at 3 weeks Xylenol orange at 6 weeks Oxytetracycline at 12 weeks 
Figure 3.26: Representative fluorescence images for CI (86.13), only slight calcium deposition at 3 weeks, 
more pronounced at 6 and 12 weeks, with areas where no calcium deposition was detected at the trans 
cortex and in the bone marrow cavity (cartilaginous tissue detected in stained ground sections at that area). 
 
  
Calcein green at 3 weeks Xylenol orange at 6 weeks Oxytetracycline at 12 weeks 
Figure 3.27: Representative fluorescence images for NCI (86.25), very slight calcium deposition in the 
endosteal area at 3 weeks, more deposition located mostly endosteally but also in the cortical area at 6 and 
9 weeks.  
 Histological evaluation  
Assessment of biocompatibility parameters (inflammation and tissue response) and 
additional observations (traumatic necrosis and foreign debris) of TI and CI were 
performed at the Marvel screws surrounding tissue of each tibia sample without any 
problems. Bone activity (resorption and formation), tissue character (cartilage formation, 
callus maturity) and healing response (defect unity) were scored at the facture ends of cis 
and trans cortices as well as in the whole gap area. 
Due to the size of the gap, each section had to be spread over two slides doubling the 
total number of thin sections. Therefore, a total of 72 Hematoxylin-Eosin (N=24), 
toluidine blue (N=24) and von Kossa stained (N=24) histological sections of two groups 
(TI:6 and CI:6) were evaluated according to ISO-Norm 10993-6:2016(E). The evaluation 
was performed by two independent observers. 
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 Semiquantitative analysis of local tissue effects 
Under the conditions of this study, neither TI nor CI demonstrated any abnormal tissue 
reactions. A physiological number of immune cells within the bone marrow cavity was 
detected in the surrounding of the Marvel screws in both groups. Individual results are 
illustrated in Table 3.8. 
Overall, no polymorphonuclear cells, eosinophils, lymphocytes, plasma cells, necrosis, 
osteolysis, fatty infiltrates or foreign debris were noted in the area of the Marvel screws 
in any of the TI or CI samples. 
A low number of macrophages was observed in 1/6 samples of TI (86.16) and 3/6 
samples of CI (86.14, 86.23, 86.24). Fibrous tissue in combination with 
neovascularization was found in 1/6 samples of TI (86.16) and in 3/6 samples of CI 
(86.13, 86.23, 86.24) in a low amount.  
 
Table 3.8: Results of biocompatibility evaluation at the Marvel screws and surrounding tissue of each tibia 




86.16 86.17 86.18 86.19 86.20 86.21 86.13 86.14 86.15 86.22 86.23 86.24
1. Inflammation
Polymorphonuclear 0 0 0 0 0 0 0 0 0 0 0 0
Eosinophils 0 0 0 0 0 0 0 0 0 0 0 0
Lymphocytes 0 0 0 0 0 0 0 0 0 0 0 0
Plasma cells 0 0 0 0 0 0 0 0 0 0 0 0
Macrophages 1 0 0 1 0 0 0 1 0 0 1 1
Giant cells 0 0 0 0 0 0 0 0 0 0 0 0
Necrosis/ osteolysis 0 0 0 0 0 0 0 0 0 0 0 0
SUB-TOTAL 1 0 0 1 0 0 0 1 0 0 1 1
SUB-TOTAL (x2) 2 0 0 2 0 0 0 2 0 0 2 2
2. Tissue response
Neovascularisation 1 0 0 0 0 0 1 0 0 0 1 1
Fibrosis/fibrous membrane 1 0 0 1 0 0 1 0 0 0 1 1
Fatty infiltrate 0 0 0 0 0 0 0 0 0 0 0 0
F.2 SUB-TOTAL 2 0 0 1 0 0 2 0 0 0 2 2
TOTAL (1.+2.) 4 0 0 3 0 0 2 2 0 0 4 4
GROUP TOTAL
Average (Ø)
Ø TI - Ø CI *
Traumatic necrosis 0 0 0 0 0 0 0 0 0 0 0 0
Foreign debris 0 0 0 0 0 0 0 0 0 0 0 0
Conclusion: Under the conditions of this study, the Test group was considered to demonstrate the following:
  X       minimal or no reaction (0.0 up to 2.9);
         slight reaction (3.0 upt to 8.9);
 _      moderate reaction (9.0 upt to 15.0);
         severe reaction (>15.1)
to the tissue as compared to the non-treaed Control group.
Evaluation zone:  Marvel screws and surrounding
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 Semiquantitative analysis of bone activity, tissue character and healing 
response in the gap area 
Individual scoring results for semiquantitative analysis of bone activity, tissue character 
and healing response in the gap area of TI and CI are illustrated in Table 3.9. 
Representative images of the histological samples can be found in Figure 3.28 A-H. 
Overall, for both groups TI and CI, bone activity parameters showed high scores for bone 
formation (Score 3-4: between 51-100% new bone formation) at the fracture ends and in 
the gap area with slightly higher bone activity for TI. No bone resorption was observed 
at the fracture ends and within the bone marrow cavity in both TI and CI. Some scattered 
osteoclasts could be seen indicating the normal bone remodeling and healing process of 
a bone defect.  
Tissue character was described based on the maturity of the callus and presence of 
endochondral ossification within the fracture gap and at the fracture ends. The mean total 
score for callus maturity was slightly higher in TI (3.67) comparing to CI (2.83), 
representing more mature bone formed within the gap area at this time point. 
At the fracture ends (cis and trans), new bone was moderately organized, characterized 
by dense but still irregularly oriented structure for TI. Moderately organized but less 
dense new bone was found in CI, with notable cartilaginous tissue isles within the defect 
area and the fracture ends. 
A higher mean total score for endochondral ossification was found in CI (1.50) compared 
to TI (0.89). In 4/6 samples of CI (86.13, 86.15, 86.22, 86.24), isles of cartilage-like 
tissue with disorganized fibrous matrix (mixture of collagen fibers and proteoglycans) 
were visible within the gap (bone marrow and trans cortex area) and in 1/6 samples 
(86.15) also at one fracture end of the trans cortex (Figure 3.28 f+h). Similar cartilage-
like isles were only found in 2/6 samples of TI in the bone marrow cavity of the defect 
(86.19, 86.21) and in one of these (86.21) also at one fracture end of the trans cortex. The 
overall healing response was characterized by a defect unity score, which showed slightly 





Table 3.9: Results for semiquantitative analysis of bone activity, tissue character and healing response in the 
gap area for TI and CI (range: 0-4) for the 17mm gap model. 
 
Cis defect trans cis defect trans cis defect trans cis defect trans cis defect trans
86.16 0 0 0 4 4 3 0 2 1 4 4 3 3 3 3
86.17 0 0 0 4 4 4 1 1 1 4 3 4 2 3 4
86.18 0 0 0 4 4 4 0 1 0 4 4 4 3 4 4
86.19 0 0 0 4 4 4 0 2 1 4 4 4 4 4 4
86.20 0 0 0 3 4 4 0 1 1 3 4 4 3 4 4
86.21 0 0 0 4 4 4 1 2 1 3 3 3 4 4 4
Mean 0.00 0.00 0.00 3.83 4.00 3.83 0.33 1.50 0.83 3.67 3.67 3.67 3.17 3.67 3.83
Mean total 
gap
86.13 0 0 0 4 4 4 1 1 1 3 3 2 4 3 2
86.14 0 0 0 4 4 4 1 0 1 4 4 4 3 3 4
86.15 0 0 0 4 3 1 0 2 1 4 3 2 2 2 2
86.22 0 0 1 3 3 3 2 2 2 3 3 3 2 3 2
86.23 0 2 3 3 2 2 1 2 3 3 2 1 2 1 0
86.24 0 0 1 3 3 2 2 3 2 3 2 2 3 2 1




Bone activity Tissue character
Healing response 
(thick section)
Bone resorption   Bone formation
Endochondral 
ossification






0.00 3.89 0.89 3.67 3.56
Control 
group
0.39 3.11 1.50 2.83
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A: Animal 86.17, TI, gap area at cis cortex, 
overview, toluidine blue, mag. 1x15.5 
 
B: Animal 86.15, CI, gap area at cis cortex, 
overview, toluidine blue, mag. 1x15.5 
 
C: Animal 86.17, TI, higher magnification, smooth 
transition zone fracture end to gap area at cis 
cortex, new bone moderately organized, 
characterized by dense but irregularly oriented 
structure, toluidine blue, mag. 1x45 
 
D: Animal 86.15, CI, higher magnification, smooth 
transition zone fracture end to gap area at cis cortex, 
new bone moderately organized, characterized by 
dense but irregularly oriented structure, toluidine 





E: Animal 86.17, TI, gap area at trans cortex, 
fracture end completely remodeled, smooth 
transition zone, new bone characterized by dense 
and regularly oriented structure at the fracture 
ends, toluidine blue, mag. 1x15.5 
 
F: Animal 86.15, CI, gap area at trans cortex, gap 
not completely united, isles of cartilage-like tissue 
with disorganized fibrous matrix (mixture of 
collagen fibers and proteoglycans) reaching to the 
fracture end, which is still pronounced, callus within 
gap disorganized, toluidine blue, mag. 1x15.5 
 
G: Animal 86.11, TI, higher magnification smooth 
transition zone between fracture end to gap area at 
trans cortex, new bone highly organized, 
characterized by dense and regularly oriented 
structure, toluidine blue, mag. 1x45 
 
H: Animal 86.15, CI, higher magnification, sharp 
transition zone between fracture end to gap area at 
trans cortex, isles of cartilage-like tissue with 
disorganized matrix reaching to the fracture end, 
toluidine blue, mag. 1x45 
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 Discussion 
In this study it was shown that internalized Pulsed Electromagnetic Field Stimulation 
enhances bone formation and callus maturation in both non-critical and critical size 
defects. In the 3 mm gap model a successful non-critical size defect was achieved with 
great standardization. Custom designed cutting guides, drill guides and aiming devices 
made for a very reproducible surgical procedure. This, along with standardized post-
operative procedures (cast changes, radiographs, daily observations), contributed to the 
absence of major complications. A reliable comparison between test item (TI) and control 
item (CI) was therefore possible. No adverse reactions related to the test item were 
noticed.  
Both groups showed good healing progress and biocompatibility. Radiographic 
evaluation presented a more advanced callus formation in the test item, which was 
corroborated with the macroscopic findings during the sacrifice. Fluorescent dye 
integration indicated more calcium deposition cortically in the TI and endosteally in the 
CI. Both Micro-CT analysis and histomorphometry proved that new bone of the test item 
had higher mineral density. Biomechanical testing, although not reaching statistical 
significance, presented a strong trend towards more advanced healing of the test item, as 
it reached twice the stiffness of the control item. Higher callus maturity of the TI was 
also confirmed during the histological evaluation, where it revealed to be qualitatively 
superior to the control item. 
 
In the 17 mm graft model great standardization was achieved as well, which prevented 
occurrence of any major complications. Good biocompatibility and no adverse reactions 
related to the test item were noticed. Radiographically, TI showed both more advanced 
healing during all timepoints and new bone formation that was focused more in the gap 
area. The radiographic findings were corroborated macroscopically, with all 6 TI tibiae 
exhibiting fragment stability compared to only 2/6 CI tibiae. Calcium deposition was 
focused more at the fracture ends in the TI and more endosteally in the CI. Statistically 
significant differences were observed regarding total callus volume and mature callus 
volume, as these values were significantly higher in TI compared to CI. A trend for higher 
callus density was also noted in the TI. These finding were corroborated with the 
histomorphometry analysis where higher callus percentage was calculated in the TI. 
Also, biomechanical testing confirmed the superiority of the test item, reaching statistical 
Discussion 
 102 
significance in torsional stiffness. Test item outperformed control item by a factor of 2.6 
times in torsional stiffness. TI also reached 67% of sound limb stiffness compared to only 
30% in CI. The same trend was seen during the histological evaluation, where denser 
new bone structure of TI compared to CI was observed. Overall, TI manifested a more 
advanced healing of the critical size defect and superior callus quality, showing better 
callus smoothness, size and opacity, compared to the CI.  
As expected in the 17 mm model, all 3 negative control samples that had not received 
bone graft inside the osteotomy, presented highly unstable and collapsed gaps both 
macroscopically and radiographically. None of the defects were filled with callus and all 
three plates were bent with a collapse of the trans cortex. In fact, bone resorption and 
rounding of the cortical bone fragments started at 9 weeks and was further pronounced 
at sacrifice, indicating a progression towards a non-union. This result was expected as 
the NCI group was designed as a negative control, in order to validate the 17mm model 
as a critical size defect model. 
 
Six sheep per group were used in this study of similar age and weight range. While 
designing a study, sufficient number of animals is often a crucial point of discussion. On 
one hand, a higher sample size could decrease variability of results and make it easier to 
detect smaller differences between groups. In a sample size that equals six, results of 
each sheep are extremely valuable, leaving no place for outliers. A higher sample size 
could therefore potentially contribute to more precise results of the researched 
technology.  
On the other hand, there are valid points speaking against increase of sample sizes. Most 
of all, the question asked in the hypothesis has been answered with only six sheep per 
group: namely, whether the Marvel technology enhances fracture healing and is safe to 
use. From the point of view of animal protection, it is very important to aim for the lowest 
number of animals that is sufficient for answering the main research question. This 
complies with the principles of the 3Rs (Replace, Reduce and Refine), which support and 
emphasize ethical use of experimental animals. Reduction in this case was achieved by 
using the minimal number of sheep, needed to obtain enough data. Concluding, it was 
proven that amount of sheep used in this research was adequate for detecting differences 
and proving the efficiency of Marvel technology. 
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There were several reasons why only female sheep were used. Male animals are difficult 
to handle and generally less patient and cooperative. A situation when both sexes are kept 
in the same stables simultaneously would be hard to manage and could cause plenty of 
complications. Especially in a study like this one, preventing animals from getting 
nervous or overexcited is of the utmost importance, as any sudden jump or movement 
could influence healing of the fracture or cause implant breakage. This would be 
extremely difficult if not impossible while keeping male and female sheep together. Male 
sheep should also not be put in the suspension systems as belts may put pressure on the 
urinary tract and cause related to it complications.  
Furthermore, females and males have different hormonal levels, which impact such 
parameters like weight, size, length of the limbs or bone metabolism. Previously 
conducted studies (Bottlang et al., 2016; Plecko et al., 2013; Plecko et al., 2012; Richter 
et al., 2015) confirm that female sheep population is representative in regards to whole 
sheep population and is also sufficiently reflecting the responses seen in human medicine 
across genders.  
 
It was important to pick sheep with calm characters. As this study required very frequent 
interactions between people and animals (putting the coils on and off twice a day, 
changing the casts, taking radiographs), having cooperative sheep was advantageous 
when it comes to efficient work and injury prevention. Sheep arrived at least two weeks 
before planned surgeries. This acclimatization time allowed 
for exclusion and substitution of anxious ones. Unfortunately, there was one sheep 
(86.01), which nervous character and constant jumps and moves over the course of the 
entire in- life duration, partly resulted in broken distal screws, bent plate and completely 
collapsed gap at the trans cortex, which was an obvious exclusion criterium. 
Overall, a good standardization was achieved with surgeries performed in a precise and 
reproducible manner. This was possible because of custom-designed cutting and drill 
guides. The whole surgical procedure was also priorly tested during multiple cadaver 
surgeries. No complications occurred in creating the transverse tibia osteotomy and its 
internal fixation. Regarding the implantation of the Marvel technology, the Marvel screw 
positioning and alignment was standardized in all cases by using a customized aiming 
device. The screws were systematically parallel to each other, which was important to 
ensure the creation of the local electric field, and positioned at standardized distances 
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from the place and the defect edge. The placement of the transducer was also successful 
in all animals with no observed displacement or any irritation of the surrounding tissue. 
While a 12-hole LCP plate was used for the 3 mm gap model without any issues, fixation 
of 17 mm defects required longer, 13-hole LCP plates, which left less space for 
manipulations. In these cases, sufficient length of the tibia was critical. To avoid 
problems, a pre-operative radiologic examination and measuring tibia length could be an 
option. Nevertheless, from our experience, choosing sheep with longer legs was an 
optimal strategy, without the need for radiographic check. 
The most problematic part of the implanted devices was cap detachment from the Marvel 
screws, which is a decisive component for this technology to work: all parts have to be 
tightly connected to each other to ensure PEMF stimulation. Unfortunately, there were 
several cases of caps detachments, mostly in CI animals but also in two TI animals (86.02 
and 86.12). In animal 86.02, cap detachment was detected at the sacrifice, with fibrous 
tissue growing between the proximal cap and the Marvel screw head, which likely 
prevented the technology from working properly. This resulted in the exclusion of the 
animal from the study. One other animal (86.12) had to undergo a re-surgery right after 
radiographic evidence of cap detachment was found five and a half weeks post 
osteotomy. Due to these multiple complications, the cap system had to be re-worked. A 
tighter fit of the transducer caps was provided so that reliable fastening of the cap at the 
hexagonal screw head was finally achieved. Thanks to this, no case of cap detachment 
occurred with reworked caps. Nonetheless, a press fit system may not be optimal for 
assuring perfect placement and contact with the Marvel screws over the course of several 
months and could be a subject of more design improvements in the future. Another 
suggestion is the development of a real time verification system or sensor to show that 
the treatment is being delivered. This could be a great strategic tool in early recognition 
of any problems related to Marvel technology function. 
PEMF treatment was successfully administered throughout the whole study. Coils and 
belts were tolerated well by animals. The use of positive reinforcement by providing hay 
during the treatment time, helped sheep acclimatize to the treatment. The belt system 
could be improved by attaching better closing mechanisms. Indeed, straps had a tendency 
to loosen with movements and required corrections to ensure optimal coil placement 
around the fracture area. The straps should also be strengthened to provide more solid 
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support of the coil. Decreasing the weight of the coil could also be a subject of 
improvement in the future.  
 
Initiating treatment after the inflammatory phase of fracture healing is complete could be 
another interesting aspect to investigate. This is in contrast to what was performed in this 
study, by initiating the treatment 3 days post-surgery. Indeed, PEMF has been described 
to enhance angiogenesis, therefore, a 3-week post trauma treatment initiation time point 
could provide potential benefits in terms of fracture healing because it would align with 
the start of angiogenesis. In addition, instead of applying two treatments per day, 
combining morning and evening treatments into one longer session could be attempted. 
This would certainly be more convenient for the patients and caregivers. Nevertheless, 
the treatment regimen applied in our studies was successful and, therefore, it makes it 
questionable to repeat animal studies to clarify these questions. Possibly, this could be 
verified in future clinical trials in humans. 
 
Regarding the choice of the 9-week end point in the 3 mm group, the in- life length was 
decided based on radiographic healing kinetics. A 9-week time point may not have been 
optimal for detection of huge differences, as the callus was already starting to 
consolidate. As known, non-critical size defects heal with time and distinguishing bigger 
differences in results could be better possible earlier, for example on the 7th or 8th week. 
This was clearly seen on the radiographs at week 6 and 7, where TI showed more callus 
focus inside the gap compared to the CI. This was also corroborated by the pattern of 
fluorescent calcium deposition at week 6, appearing more cortical in TI and more 
endosteal in CI. These findings support the potential idea of earlier sacrifice time point 
in order to detect bigger differences of healing.  
In the 17mm graft model, none of the defects were radiographically completely healed 
after 12 weeks. The sacrifice time point was chosen based on radiographic evidence of 
new bone formation and was aimed at detecting the largest difference in remodelling 
kinetics. In this case, the 12 week in-life duration was optimal for distinguishing these 
differences between the TI and CI.  
The other aspect is optimizing radiographic examination intervals to reduce the need of 
sheep handling and cast changes. The 4th and 5th week timepoints did not provide any 
additional value in assessing healing kinetics. That being said, the weekly radiographic 
Discussion 
 106 
follow-up was necessary in this case, because a new technology was being tested. 
Intermediate radiological timepoints could be skipped if a similar technology is tested in 
the future. Therefore, if future studies are planned, performing radiographs would be 
suggested in non-critical size defect animals at the following intervals: post OP, 3rd 
week, 6th week and weekly thereafter until sacrifice.   
 
During the application of fluorescent dyes, pre- surgical weight was always used, 
therefore potentially under- or overestimating the weight of the animal at the injections 
time. All animals were weighed only once throughout the course of the entire study as 
there was no clinical reason to weigh them post-operatively. In addition, transporting 
them to another building in order to weight them would cause too much stress, 
uncontrolled movement and increased the danger of re-fracture. This added risk would 
not compensate the benefits of administering a more accurate dose of fluorescent dyes as 
the variation in weight was deemed small. Therefore, dosages of injected fluorescent 
dyes could be slightly higher for the sheep that lost weight and slightly lower for the ones 
that put weight on. Nevertheless, minor discrepancies in dosage was acceptable for the 
qualitative assessment of the fluorescent sections. 
Evaluating these sections mostly relies on their thickness as more dye is accumulated in 
the thicker sections. Thickness of the slides depended on the manual adjustment of the 
saw during the process of cutting and was therefore not always the same. Measuring slide 
thickness was done in order to choose the ones with the most similar values, however, 
differences were often encountered. For future evaluations, a calibration method for 
normalizing signal intensity would be useful. Alternatively, one could still reliably assess 
the localization of calcium integration, rather than the signal intensity. In this case, slide 
thickness variation would not be a problem. 
 
Various methods of callus size measurement were performed. A quantitative 
radiographic analysis was attempted for all timepoints and all animals but it did not 
provide accurate data. In the cranial (275°) projection, the measurements were not 
possible, as often wires, caps and Marvel screws covered the areas of interest. Also, 
because the endosteal callus could not be measured by those means, only callus at the 
trans cortex in the anteroposterior (0°) projection and callus at the caudal cortex in the 
caudal (265°) projection were measured, delivering a very limited set of data. Also, 
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measurements of callus size were done during macroscopic evaluation. This method 
proved to be very inaccurate and difficult to standardize because the macroscopic 
detection of callus boundaries was not always clear, especially in very smooth calluses. 
Morphometric measurements were performed using Micro-CT scans. This examination 
was definitely a very reliable and helpful method in assessing healing progress 
objectively. Using calibration protocols, callus density could be converted from 
Hounsfield Units to mineralization (in mg hydroxyapatite per cm3). The most challenging 
part of the 3D segmentation was that new bone often happened to be as dense as the old 
bone, which made it difficult to distinguish using automated density thresholding (see 
Figure 4.1). In some cases, the amount of this unidentified, mature, rigid callus would 
make the majority of the whole new bone formation. For that reason, in order to 
accurately segment new bone from old bone, manual slice by slice tissue selection had 
to be accomplished at the University of Lehigh. 
 
 
Figure 4.1: Callus volume calculation of the same sample using automated density thresholding (A) versus slice 
by slice tissue segmentation (B). Density thresholding resulted in falsely recognizing mature callus (see arrows 
in Figure A) as cortical bone due to its high mineral density. Slice by slice selection, however, successfully 
distinguished old bone from the new bone formation, thereby providing a more accurate callus volume. 
Non- destructive mechanical test was the chosen evaluation method, as it was essential 
to keep the osteotomy area intact for the histology processing. If there were any 
abnormalities related to the testing procedure, a test could be repeated, as the tissue would 
not be damaged. This was not often a case, however, would be impossible after 
performing destructive testing. Destructive tests would certainly be very interesting and 
could provide more complete information regarding bone properties. Nevertheless, the 
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principle of the 3Rs speaks against it as in the case of destructive mechanical testing, 
different samples would have to be used for histological examination, thereby requiring 
twice the number of samples and therefore twice the number of animals. A non-
destructive mechanical test was therefore a good compromise. 
The slope of the linear part of the loading curves was generated automatically to calculate 
torsional stiffness. The loading curves had to be checked to ensure the slope was correctly 
evaluated. In several cases the curve profiles looked abnormal or did not reach the 
targeted 10 Nm. It was essential that the higher part of the curve that was linear was 
selected as it was more representative of bone stiffness. Analysing every single loading 
curve was also important to ensure the mechanical testing was performed successfully. 
Even though most of these calculations were automated, it was nevertheless necessary to 
verify them. 
Overall, looking at intact tibiae, biomechanical testing exhibited an inherent 21% relative 
standard deviation, likely coming from both interanimal differences and potting 
technique. Whether increase in the number of sheep could influence this high variability 
stays an open question. Non-operated tibiae were very similar in torsional stiffness. There 
are no major differences in bone stiffness variability between TI and CI. The 3mm gap 
model sheep showed a 26% relative standard deviation compared to only 14% in the 
17mm model. This difference was a contributing factor in the ability to detect statistical 
significance in the 17 mm model study but not in the 3 mm. A more detailed group 
distribution is presented in the Table 4.1. This proves that interanimal differences, in this 
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6 7.51 ± 1.81 24.1 
Control 
Item (CI) 
6 6.04 ± 1.51 25.0 
TI + CI 12 6.77 ± 1.76 26.0 




6 8.47 ± 0.93 11.0 
Control 
item (CI) 
6 7.46 ± 1.15 15.4 
TI + CI 12 7.96 ± 1.13 14.2 
Both All 24 7.37 ± 1.57 21.3 
Table 4.1: Torsional stiffness of intact tibia across groups reported as mean ± SD. The relative standard 
deviation is also reported to indicate interanimal variability within groups. 
 
Another potentially interesting analysis would be testing the biomechanics of the callus 
area specifically, and not the tibia as a whole, which was the case in this study. This 
would require placing some markers on the callus and tracking the displacement of the 
callus in real time during a mechanical test. 
 
Histological evaluations relied in part on analysing ground sections. It needs to be 
emphasized, however, that one slide does not represent bone as a whole and this must be 
taken into account during the evaluation. Indeed, in some samples (for instance, sheep 
86.20 and 21), although full defect closure was not detected on one ground section 
(Figure 4.2 A), evident progress in new bone formation and even callus bridging was 
nevertheless seen in the consecutive ground section (Figure 4.2 B). Thin sections could 




Figure 4.2 (A, B): Comparison of two consecutive ground section slides of animal 86.20, showing no bridging 
callus at the cis cortex area on the first section (A) and bridging callus on the consecutive section(B). 
 
Tissue loss due to sample processing, like cutting or polishing is another problem. Most 
of the evaluated histology slides corresponded well to radiographic, Micro-CT or 
biomechanical findings. Bone formation seen under the microscope usually reflected 
well if bridging callus was apparent and if fragment stability was achieved. Nevertheless, 
in some cases, histology showed inferior bone healing compared to other methods. 
Because of these reasons, multiple histological slides should be examined and histology 
should always be evaluated together with other methods and never alone. 
 
This study definitely shed some new light on electromagnetic influence on bone healing. 
Electromagnetism is not a new concept, however, the majority of so far conducted studies 
showed little standardization or compared very different forms of PEMF. It is not 
uncommon to find different treatment lengths (from 10 minutes to 12 or even 24 hours a 
day) (Fredericks et al., 2000; Sharrard, 1990), durations (days, weeks, months)(Dallari 
et al., 2009; Ding et al., 2011; Midura et al., 2005; Sharrard, 1990), various start points 
(delayed unions of 16 weeks to 6 months within the same study) (Shi et al., 2013), usage 
of other types of stimulating devices (Midura et al., 2005) and different parameters 
(different PEMF signal configuration, repetition frequency, pulse duration and shape 
amongst others) (Dhawan et al., 2004; Mammi et al., 1993).  
Moreover, most of human studies show large variations regarding age, affected bones, 
environmental influence, presence of predisposing factors (smoking, diabetes). 
These heterogeneous treatment regime and sample groups exerted a tremendous 
influence on the outcome of each study and were reflected in dramatically varied results: 
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PEMF success rate ranging from 15.4 to 93.9 % (Shi et al., 2013). Moreover, there were 
no optimal device parameters established by now and none of the studies used direct 
electric stimulation and provided detailed systematic analysis, which was a case in this 
research thanks to the implementation of the transducer and the Marvel screws, acting as 
electrodes, on both sides of the defect. The majority of already conducted studies also 
reported beginning of the treatment only after non-union establishment, delivering little 
information about early stage application. In these few reports on both fresh human 
fractures and animal osteotomies, bones responded better to PEMF when treatment began 
soon after trauma. 
 
From our experience, earlier treatment implementation is essential not only in non- union 
prevention but also in healing time shortening. 
It would be suggested that standard PEMF treatment is implemented in all patients at 
risk: diabetic, elderly, smokers or with fractures that could potentially evolve in delayed 
or non- unions: displaced, infected and with big gaps. This would decrease healing time 






The chosen animal models were appropriate to evaluate the effect of the Marvel 
technology on bone healing in both, a non-critical and a critical size bone defect 
augmented with autograft. There were no abnormalities or healing complications related 
to the Marvel technology which proved to be both safe and effective. Furthermore, the 
Marvel therapy accelerated and enhanced the healing process in both models, resulting 
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 Abbreviation list 
 
BID Two times per day 
BW Body Weight 
CI Control Item 
HU Hounsfield Units 
im intramuscularly 
iv intravenously 
MSRU Musculoskeletal Research Unit 
n/a, N/A not applicable 
NaCl Sodium Chloride 
NCI Negative Control Item 
Nm Newton meter 
OA Osteoarthritis 
PEMF Pulsed Electromagnetic Field Therapy 
ROI Region of interest 
sc subcutaneously 
SID Once per day 
SOP Standard Operating Procedure 
TI Test Item 
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 Appendices 
 Appendix 1  
 
 








Intra-OP Notes Recovery Abnormalities
86.01 427 91.4 - -
86.02 433 92.2 - -
86.03 434 90.5
The transducer was replaced because of the too 





The cauter was not available during the first part of 
the surgery (cut, access to the bone), therefore, 
more bleeding occured. Post surgical radiographs 
revealed that the distal transducer cap+G14 was 
loose. The sheep underwent the next surgery right 
after, the cap was placed on the screw head again. 
Resistance measurement was higher in 
comparison to the one measured during the first 
surgery. 
-
86.11 416 92 - -
86.12 436 96
Due to the cap loosening 5 weeks after the surgery, 
the sheep underwent a second surgery. A single 5 
cm long cut was made cranio- medially from the 
plate, proximal cap was re- attached. 
-
86.28 601 93.6 - -
86.29 529 93.5 - -
86.04 418 91.5 - -
86.05 428 90.8 - -
86.06 417 92.4 - -
86.07 431 92 -
Stopped breathing after the 
extubation, intubated again, 
mechanically ventilated, 
received oxygen, stabilized 
after about an hour, 
extubated.
86.08 423 91.7 - -
86.09 432 91.4
First inserted transducer had to be replaced 































 Appendix 2 
 
 











Intra-OP Notes Recovery Abnormalities
86.16 505 94.1 - -
86.17 498 92.6 - -
86.18 474 101.5
There was a problem with the aiming device and 
the cuts were therefore not parallel (about 1mm off). 
The alignment of the distal and proximal tibia, 
however, seemed good, despite that cut 
misalignment.
-
86.19 505 91.6 -
86.20 516 91.1 - -
86.21 487 94.8 - -
86.13 482 -
Implanted transducer does not work, but it is a 
sham sheep so it will have no impact.
-
86.14 477 92.2 -
86.15 493 107.7
Not much bleeding from bone marrow (unlike 








86.23 600 38 - -
86.24 480 99.8 - -
86.25 419 - - -
86.26 486 - - -
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 Appendix 3: Radiographs 
 
Figure 7.1: Radiographic summary at 9 weeks post-operatively for all animals in 3mm gap model. 
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 Appendix 4: Macroscopic evaluation pictures 
 
Figure 7.4: Macroscopic images (medial view) of all animals in 3mm gap model. 
 
 
Figure 7.5: Macroscopic images (caudal view) of all animals in 3mm gap model. 
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Figure 7.6: Macroscopic images (medial view) of TI and CI animals in 17mm graft model. 
 
 
Figure 7.7: Macroscopic images (caudal view) of TI and CI animals in 17mm graft model. 
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 Appendix 5: Histology 
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Figure 7.11: Ground sections surface stained with Toluidine Blue of all processed negative control 17mm model 
samples. 
 
 Appendix 6: Micro-CT scans 
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TI operated Non-operated 









































































TI operated Non-operated 
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TI operated Non-operated 























































CI operated Non-operated 
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CI operated Non-operated 








































































CI operated Non-operated 
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Figure 7.12 Micro-CT scans of both operated and non-operated tibiae of all sheep. 
  
NCI operated 
3D rendering Sagital Transversal 
   
86.25 left 
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 Appendix 7: Biomechanics 
 
Figure 7.13: Torsional stiffness in Nm/deg and torsional stiffness of operated tibiae normalized to contralateral 
tibiae, shown per animal treated with CI or TI in the 3 mm gap model. 
 
Figure 7.14: Torsional stiffness in Nm/deg and torsional stiffness of operated tibiae normalized to 
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